Plant aminoacyl-tRNA synthetases

ABSTRACT

This invention relates to an isolated nucleic acid fragment encoding an aminoacyl-tRNA synthetase. The invention also relates to the construction of a chimeric gene encoding all or a portion of the aminoacyl-tRNA synthetase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the aminoacyl-tRNA synthetase in a transformed host cell.

[0001] This application is a divisional of U.S. patent application Ser. No. 09/436699, filed Nov. 4, 1999, which is hereby incorporated herein by reference in its entirety which claims the benefit of U.S. Provisional Application No. 60/107,276, filed Nov. 5, 1998.

FIELD OF THE INVENTION

[0002] This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding aminoacyl-tRNA synthetases in plants and seeds.

BACKGROUND OF THE INVENTION

[0003] Aminoacyl-tRNA Synthetases (AARS) are enzymes that charge (acylate) tRNAs with amino acids. These charged aminoacyl tRNAs then participate in mRNA translation and protein synthesis. The AARS show high specificity for charging a specific tRNA with the appropriate amino acid, for example valyl-tRNA with valine by valyl-tRNA synthetase or tryptophanyl-tRNA with tryptophan by tryptophanyl-tRNA synthetase. In general, per organism there are is at least one AARS for each of the twenty amino acids. There are exceptions however. AARS are ancient enzymes, having functioned in translation since early life evolution. Some have speculated that the earliest aminoacyl-tRNA synthetases were mRNAs, not proteins, with the proteinaceous AARS described here emerging later (Neidhardt et al., (1975) Annu. Rev. Microbiol. 29:215-250). AARS are structurally diverse, although AARSs for some amino acids are more closely related than for others. AARSs are generally divided into two classes, class I and class II, based on structural similarity and amino acid preferences (Eriani et al., (1990) Nature 347:203-206).

[0004] Plants like all other cellular organisms have aminoacyl-tRNA synthetases. However, a full description of the plant ‘complement’ of aminoacyl-tRNA synthetases has not yet been described. Full-length cDNA, genomic clones, and EST sequences for a variety of plant aminoacyl-tRNA synthetases are known. However, several anticipated aminoacyl-tRNA synthetases have not been discovered.

[0005] Because of the central role of protein synthesis in life, any agent that inhibits or disrupts this activity is likely to be toxic. Aminoacyl-tRNA synthetases play a critical role in protein translation by linking genetic nucleic acid information to protein synthesis. Aminoacyl-tRNA synthetases perform this role by “reading” the identity of the different tRNAs and acylating them with the correct cognate amino acid. A large volume of research over several decades has been focused on identifying inhibitors of this process. Inhibitors of aminoacyl-tRNA synthetases have been found to be cytotoxic due to their inhibition of protein synthesis. As such they therefore could be used as herbicides or in aminoacyl-tRNA synthetase selectable marker systems (Lloyd et al., (1995) Nucleic Acid Research 23(15):2882-2892). The genes disclosed herein can serve as the basis for testing whether the encoded aminoacyl-tRNA synthetases are sensitive to known inhibitors or other chemicals.

[0006] Biochemical processes are often compartmentalized in regions of cells, such as mitochondria, plastids, and lysosomes. These organelles are key sites for many biochemical pathways. Bioengineering of these processes may require targeting protein products to specific organelles. One method to accomplish this involves the addition of an N-terminal prosequence (transit peptide) that directs protein entry into a specific organelle(s). Upon or shortly after transport into the organelle the transit peptide is usually proteolytically removed, and the mature protein is then able to function.

[0007] A few plant transit peptides have been shown empirically to be capable of directing fused proteins into specific organelles. However this ability appears to depend upon the structure of the protein being imported and to date it is impossible to predict whether a protein will be imported into an organelle with a given transit peptide. As such, it is advantageous to have a diversity of potential transit peptides from which the most efficient candidate can be chosen to target a protein of interest to an organelle. A number of plant transit peptides are known which direct mature proteins to mitochondria or chloroplast organelles. These transit peptides are diverse in structure (length and amino acid sequence) and there is no strong consensus sequence identifying them. In addition, there is no obvious clear relationship between chloroplast targeting and mitochondrial targeting transit sequences. This invention describes a number of chloroplast-targeting and mitochondria-targeting transit peptides for (maize) aminoacyl-tRNA synthetases. These sequences will find utility in directing both aminoacyl-tRNA synthetase and other proteins into these organelles.

[0008] Accordingly, the availability of nucleic acid sequences encoding all or a portion of these enzymes would facilitate studies to better understand protein synthesis in plants, provide genetic tools for the manipulation of gene expression, protein targeting to specific organelles and provide possible targets for herbicides.

SUMMARY OF THE INVENTION

[0009] The present invention relates to isolated polynucleotides comprising a nucleotide sequence encoding a first polypeptide of at least 116 amino acids that has at least 85% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of a rice seryl-tRNA synthetase polypeptide of SEQ ID NO:16, a soybean seryl-tRNA synthetase polypeptide of SEQ ID NO:18, or a wheat seryl-tRNA synthetase polypeptide of SEQ ID NO:20. The present invention also relates to an isolated polynucleotide comprising the complement of the nucleotide sequences described above.

[0010] The present invention also relates to isolated polynucleotides comprising a nucleotide sequence encoding a second polypeptide of at least 483 amino acids that has at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of a corn threonyl-tRNA synthetase polypeptide of SEQ ID NO:22, a rice threonyl-tRNA synthetase polypeptide of SEQ ID NO:24, a soybean threonyl-tRNA synthetase polypeptide of SEQ ID NO:26, or a wheat threonyl-tRNA synthetase polypeptide of SEQ ID NO:28. The present invention also relates to an isolated polynucleotide comprising the complement of the nucleotide sequences described above.

[0011] The present invention relates to an isolated polynucleotide comprising a nucleotide sequence encoding a first polypeptide of at least 30 amino acids that has at least 70% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12 and 14.

[0012] It is preferred that the isolated polynucleotides of the claimed invention consists of a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 and 27 that codes for the polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 and 28. The present invention also relates to an isolated polynucleotide comprising a nucleotide sequences of at least one of 40 (preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 and 27 and the complement of such nucleotide sequences.

[0013] The present invention relates to a chimeric gene comprising an isolated polynucleotide of the present invention operably linked to suitable regulatory sequences.

[0014] The present invention also relates to the identification of transit peptides associated with aminoacyl-tRNA synthetases of the instant invention and the use of those transit peptides to target aminoacyl-tRNA synthetases and other operably linked proteins to specific organelles within plant cells. Transit peptide amino acid sequences are located just upstream of the mature aminoacyl-tRNA synthetase polypeptide sequences disclosed in the instant invention.

[0015] The present invention relates to an isolated host cell comprising a chimeric gene of the present invention or an isolated polynucleotide of the present invention. The host cell may be eukaryotic, such as a yeast or a plant cell, or prokaryotic, such as a bacterial cell. The present invention also relates to a virus, preferably a baculovirus, comprising an isolated polynucleotide of the present invention or a chimeric gene of the present invention.

[0016] The present invention relates to a process for producing an isolated host cell comprising a chimeric gene of the present invention or an isolated polynucleotide of the present invention, the process comprising either transforming or transfecting an isolated compatible host cell with a chimeric gene or isolated polynucleotide of the present invention.

[0017] The present invention relates to a seryl-tRNA synthetase polypeptide of at least 116 amino acids comprising at least 85% homology based on the Clustal method of alignment compared to a polypeptide selected from the group consisting of SEQ ID NOs:16, 18 and 20.

[0018] The present invention alos also relates to a threonyl-tRNA synthetase polypeptide of at least 483 amino acids comprising at least 80% homology based on the Clustal method of alignment compared to a polypeptide selected from the group consisting of SEQ ID NOs:20, 22, 24, 26 and 28.

[0019] The present invention relates to a method of selecting an isolated polynucleotide that affects the level of expression of a seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide in a host cell, preferably a plant cell, the method comprising the steps of:

[0020] constructing an isolated polynucleotide of the present invention or an isolated chimeric gene of the present invention;

[0021] introducing the isolated polynucleotide or the isolated chimeric gene into a host cell;

[0022] measuring the level a seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide in the host cell containing the isolated polynucleotide; and

[0023] comparing the level of a seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide in the host cell containing the isolated polynucleotide with the level of a seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide in a host cell that does not contain the isolated polynucleotide.

[0024] The present invention relates to a method of obtaining a nucleic acid fragment encoding a substantial portion of a seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide gene, preferably a plant seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide gene, comprising the steps of: synthesizing an oligonucleotide primer comprising a nucleotide sequence of at least one of 40 (preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 and 27 and the complement of such nucleotide sequences; and amplifying a nucleic acid fragment (preferably a cDNA inserted in a cloning vector) using the oligonucleotide primer. The amplified nucleic acid fragment preferably will encode a portion of a seryl-tRNA synthetase or threonyl-tRNA synthetase amino acid sequence.

[0025] The present invention also relates to a method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide comprising the steps of: probing a cDNA or genomic library with an isolated polynucleotide of the present invention; identifying a DNA clone that hybridizes with an isolated polynucleotide of the present invention; isolating the identified DNA clone; and sequencing the cDNA or genomic fragment that comprises the isolated DNA clone.

[0026] A further embodiment of the instant invention is a method for evaluating at least one compound for its ability to inhibit the activity of a seryl-tRNA synthetase or threonyl-tRNA synthetase, the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment encoding an aminoacyl-tRNA synthetase polypeptide, operably linked to suitable regulatory sequences; (b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of an aminoacyl-tRNA synthetase polypeptide in the transformed host cell; (c) optionally purifying the aminoacyl-tRNA synthetase expressed by the transformed host cell; (d) treating the amino-acyl-tRNA synthetase with a compound to be tested; and (e) comparing the activity of the aminoacyl-tRNA synthetase that has been treated with a test compound to the activity of an untreated aminoacyl-tRNA synthetase, thereby selecting compounds with potential for inhibitory activity.

[0027] The present invention relates to a composition comprising an isolated polynucleotide or polypeptide of the present invention.

[0028] The present invention relates to an expression cassette comprising an isolated polynucleotide of the present invention.

[0029] The present invention relates to a method for positive selection of a transformed cell comprising:

[0030] (a) transforming a plant cell, preferably a monocot such as corn, with a chimeric gene of the present invention or an expression cassette of the present invention; and

[0031] (b) growing the transformed plant under conditions allowing expression of the polynucleotide in an amount sufficient to complement an amiono acyl-tRNA synthetase.

[0032] As used herein, the following terms shall apply:

[0033] “Aminoacyl-tRNA synthetase” refers to seryl-tRNA synthetase and/or threonyl-tRNA synthetase.

BRIEF DESCRIPTION OF THE SEQUENCE DESCRIPTIONS

[0034] The invention can be more fully understood from the following detailed description and the accompanying Sequence Listing which form a part of this application.

[0035] Table 1 lists the polypeptides that are described herein, the designation of the cDNA clones that comprise the nucleic acid fragments encoding polypeptides representing all or a substantial portion of these polypeptides, and the corresponding identifier (SEQ ID NO:) as used in the attached Sequence Listing. Table 1 also identifies the cDNA clones as individual ESTs (“EST”), the sequences of the entire cDNA inserts comprising the indicated cDNA clones (“FIS”), contigs assembled from two or more ESTs (“Contig”), contigs assembled from an FIS and one or more ESTs (“Contig*”), or sequences encoding the entire protein derived from an FIS, a contig, or an FIS and PCR (“CGS”). Nucleotide sequences, SEQ ID NOs:15, 17, 19, 21, 23, 25 and 27 and amino acid sequences SEQ ID NOs:16, 18, 20, 22, 24, 26 and 28 were determined by further sequence analysis of cDNA clones encoding the amino acid sequences set forth in SEQ ID NOs:2, 4, 6, 8, 10, 12 and 14. Nucleotide SEQ ID NOs:1, 3, 5, 7, 9, 11 and 13 and amino acid SEQ ID NOs:2, 4, 6, 8, 10, 12 and 14 were presented in a U.S. Provisional Application No. 60/107,276, filed Nov. 5, 1998.

[0036] The sequence descriptions and Sequence Listing attached hereto comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R. §1.821-1.825. TABLE 1 Aminoacyl-tRNA Synthetases SEQ ID NO: (Nucle- (Amino Protein Clone Designation otide) Acid) Seryl-tRNA Synthetase r1r6.pk0023.e9 (EST) 1 2 Seryl-tRNA Synthetase s12.pk123.g22 (EST) 3 4 Seryl-tRNA Synthetase w1m4.pk008.d5 (EST) 5 6 Threonyl-tRNA Synthetase cr1n.pk0140.b10 (EST) 7 8 Threonyl-tRNA Synthetase r1r6.pk0084.e1 (EST) 9 10 Threonyl-tRNA Synthetase srr1c.pk003.k12 (EST) 11 12 Threonyl-tRNA Synthetase wr1.pk181.e1 (EST) 13 14 Seryl-tRNA Synthetase r1r6.pk0023.e9 (CGS) 15 16 Seryl-tRNA Synthetase s12.pk123.g22 (FIS) 17 18 Seryl-tRNA Synthetase w1m4.pk0018.d5 (CGS) 19 20 Threonyl-tRNA Synthetase p0017.cespf50r (CGS) 21 22 Threonyl-tRNA Synthetase res1c.pk005.j13 (FIS) 23 24 Threonyl-tRNA Synthetase srr1c.pk003.k12 (FIS) 25 26 Threonyl-tRNA_Synthetase w1m96.pk060.l13 (FIS) 27 28

[0037] The Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Res. 13:3021-3030 (1985) and in the Biochemical J. 219 (No. 2):345-373 (1984) which are herein incorporated by reference. The symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. §1.822.

DETAILED DESCRIPTION OF THE INVENTION

[0038] In the context of this disclosure, a number of terms shall be utilized. As used herein, a “polynucleotide” is a nucleotide sequence such as a nucleic acid fragment. A polynucleotide may be a polymer of RNA or DNA that is single- or double-stranded, that optionally contains synthetic, non-natural or altered nucleotide bases. A polynucleotide in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA, or synthetic DNA. An isolated polynucleotide of the present invention may include at least one of 60 contiguous nucleotides, preferably at least one of 40 contiguous nucleotides, most preferably one of at least 30 contiguous nucleotides, of the nucleic acid sequence of the SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 and 27.

[0039] As used herein, “substantially similar” refers to nucleic acid fragments wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, but do not affect the functional properties of the polypeptide encoded by the nucleotide sequence. “Substantially similar” also refers to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid fragment to mediate alteration of gene expression by gene silencing through for example antisense or co-suppression technology. “Substantially similar” also refers to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotides that do not substantially affect the functional properties of the resulting transcript vis-à-vis the ability to mediate gene silencing or alteration of the functional properties of the resulting protein molecule. It is therefore understood that the invention encompasses more than the specific exemplary nucleotide or amino acid sequences and includes functional equivalents thereof.

[0040] Substantially similar nucleic acid fragments may be selected by screening nucleic acid fragments representing subfragments or modifications of the nucleic acid fragments of the instant invention, wherein one or more nucleotides are substituted, deleted and/or inserted, for their ability to affect the level of the polypeptide encoded by the unmodified nucleic acid fragment in a plant or plant cell. For example, a substantially similar nucleic acid fragment representing at least one of 30 contiguous nucleotides derived from the instant nucleic acid fragment can be constructed and introduced into a plant or plant cell. The level of the polypeptide encoded by the unmodified nucleic acid fragment present in a plant or plant cell exposed to the substantially similar nucleic fragment can then be compared to the level of the polypeptide in a plant or plant cell that is not exposed to the substantially similar nucleic acid fragment.

[0041] For example, it is well known in the art that antisense suppression and co-suppression of gene expression may be accomplished using nucleic acid fragments representing less than the entire coding region of a gene, and by nucleic acid fragments that do not share 100% sequence identity with the gene to be suppressed. Moreover, alterations in a nucleic acid fragment which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded polypeptide, are well known in the art. Thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the polypeptide molecule would also not be expected to alter the activity of the polypeptide. Each of the proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity of the encoded products. Consequently, an isolated polynucleotide comprising a nucleotide sequence of at least one of 60 (preferably at least one of 40, most preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 and 27 and the complement of such nucleotide sequences may be used in methods of selecting an isolated polynucleotide that affects the expression of a polypeptide (such as aminoacyl-tRNA synthetase) in a plant cell. A method of selecting an isolated polynucleotide that affects the level of expression of a polypeptide in a host cell (eukaryotic, such as plant or yeast, prokaryotic such as bacterial, or viral) may comprise the steps of: constructing an isolated polynucleotide of the present invention or an isolated chimeric gene of the present invention; introducing the isolated polynucleotide or the isolated chimeric gene into a host cell; measuring the level of a polypeptide in the host cell containing the isolated polynucleotide; and comparing the level of a polypeptide in the host cell containing the isolated polynucleotide with the level of a polypeptide in a host cell that does not contain the isolated polynucleotide.

[0042] Moreover, substantially similar nucleic acid fragments may also be characterized by their ability to hybridize. Estimates of such homology are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art (Hames and Higgins, Eds. (1985) Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.). Stringency conditions can be adjusted to screen for moderately similar fragments, such as homologous sequences from distantly related organisms, to highly similar fragments, such as genes that duplicate functional enzymes from closely related organisms. Post-hybridization washes determine stringency conditions. One set of preferred conditions uses a series of washes starting with 6×SSC, 0.5% SDS at room temperature for 15 min, then repeated with 2×SSC, 0.5% SDS at 45° C. for 30 min, and then repeated twice with 0.2×SSC, 0.5% SDS at 50° C. for 30 min. A more preferred set of stringent conditions uses higher temperatures in which the washes are identical to those above except for the temperature of the final two 30 min washes in 0.2×SSC, 0.5% SDS was increased to 60° C. Another preferred set of highly stringent conditions uses two final washes in 0.1×SSC, 0.1% SDS at 65° C.

[0043] Substantially similar nucleic acid fragments of the instant invention may also be characterized by the percent identity of the amino acid sequences that they encode to the amino acid sequences disclosed herein, as determined by algorithms commonly employed by those skilled in this art. Suitable nucleic acid fragments (isolated polynucleotides of the present invention) encode polypeptides that are at least 70% identical, preferably at least 80% identical to the amino acid sequences reported herein. Preferred nucleic acid fragments encode amino acid sequences that are at least 85% identical to the amino acid sequences reported herein. More preferred nucleic acid fragments encode amino acid sequences that are at least 90% identical to the amino acid sequences reported herein. Most preferred are nucleic acid fragments that encode amino acid sequences that are at least 95% identical to the amino acid sequences reported herein. Suitable nucleic acid fragments not only have the above homologies but typically encode a polypeptide having at least 50 amino acids, preferably at least 100 amino acids, more preferably at least 150 amino acids, still more preferably at least 200 amino acids, and most preferably at least 250 amino acids. Sequence alignments and percent identity calculations were performed using the Megalign program of the LASERGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5.

[0044] A “substantial portion” of an amino acid or nucleotide sequence comprises an amino acid or a nucleotide sequence that is sufficient to afford putative identification of the protein or gene that the amino acid or nucleotide sequence comprises. Amino acid and nucleotide sequences can be evaluated either manually by one skilled in the art, or by using computer-based sequence comparison and identification tools that employ algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol. Biol. 215:403-410; see also www.nebi.nlm.nih.gov/BLAST/). In general, a sequence of ten or more contiguous amino acids or thirty or more contiguous nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene. Moreover, with respect to nucleotide sequences, gene-specific oligonucleotide probes comprising 30 or more contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques). In addition, short oligonucleotides of 12 or more nucleotides may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers. Accordingly, a “substantial portion” of a nucleotide sequence comprises a nucleotide sequence that will afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence. The instant specification teaches amino acid and nucleotide sequences encoding polypeptides that comprise one or more particular plant proteins. The skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above.

[0045] “Codon degeneracy” refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment comprising a nucleotide sequence that encodes all or a substantial portion of the amino acid sequences set forth herein. The skilled artisan is well aware of the “codon-bias” exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a nucleic acid fragment for improved expression in a host cell, it is desirable to design the nucleic acid fragment such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell.

[0046] “Synthetic nucleic acid fragments” can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form larger nucleic acid fragments which may then be enzymatically assembled to construct the entire desired nucleic acid fragment. “Chemically synthesized”, as related to nucleic acid fragment, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of nucleic acid fragments may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the nucleic acid fragments can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias of the host cell. The skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased towards those codons favored by the host. Determination of preferred codons can be based on a survey of genes derived from the host cell where sequence information is available.

[0047] “Gene” refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5′ non-coding sequences) and following (3′ non-coding sequences) the coding sequence. “Native gene” refers to a gene as found in nature with its own regulatory sequences. “Chimeric gene” refers any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature. “Endogenous gene” refers to a native gene in its natural location in the genome of an organism. A “foreign” gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer. Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes. A “transgene” is a gene that has been introduced into the genome by a transformation procedure.

[0048] “Coding sequence” refers to a nucleotide sequence that codes for a specific amino acid sequence. “Regulatory sequences” refer to nucleotide sequences located upstream (5′ non-coding sequences), within, or downstream (3′ non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences.

[0049] “Promoter” refers to a nucleotide sequence capable of controlling the expression of a coding sequence or functional RNA. In general, a coding sequence is located 3′ to a promoter sequence. The promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers. Accordingly, an “enhancer” is a nucleotide sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic nucleotide segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a nucleic acid fragment to be expressed in most cell types at most times are commonly referred to as “constitutive promoters”. New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by Okamuro and Goldberg (1989) Biochemistry of Plants 15:1-82. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, nucleic acid fragments of different lengths may have identical promoter activity.

[0050] The “translation leader sequence” refers to a nucleotide sequence located between the promoter sequence of a gene and the coding sequence. The translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence. The translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner and Foster (1995) Mol. Biotechnol. 3:225-236).

[0051] The “3′ non-coding sequences” refer to nucleotide sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3′ end of the mRNA precursor. The use of different 3′ non-coding sequences is exemplified by Ingelbrecht et al. (1989) Plant Cell 1:671-680.

[0052] “RNA transcript” refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from post-transcriptional processing of the primary transcript and is referred to as the mature RNA. “Messenger RNA (mRNA)” refers to the RNA that is without introns and that can be translated into polypeptide by the cell. “cDNA” refers to a double-stranded DNA that is complementary to and derived from mRNA. “Sense” RNA refers to an RNA transcript that includes the mRNA and so can be translated into a polypeptide by the cell. “Antisense RNA” refers to an RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (see U.S. Pat. No. 5,107,065, incorporated herein by reference). The complementarity of an antisense RNA may be with any part of the specific nucleotide sequence, i.e., at the 5′ non-coding sequence, 3′ non-coding sequence, introns, or the coding sequence. “Functional RNA” refers to sense RNA, antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes.

[0053] The term “operably linked” refers to the association of two or more nucleic acid fragments on a single nucleic acid fragment so that the function of one is affected by the other. For example, a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation.

[0054] The term “expression”, as used herein, refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide. “Antisense inhibition” refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein. “Overexpression” refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms. “Co-suppression” refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Pat. No. 5,231,020, incorporated herein by reference).

[0055] “Altered levels” refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms.

[0056] “Mature” protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed. “Precursor” protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals.

[0057] A “chloroplast transit peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the chloroplast or other plastid types present in the cell in which the protein is made. “Chloroplast transit sequence” refers to a nucleotide sequence that encodes a chloroplast transit peptide. A “signal peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the secretory system (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53). If the protein is to be directed to a vacuole, a vacuolar targeting signal (supra) can further be added, or if to the endoplasmic reticulum, an endoplasmic reticulum retention signal (supra) may be added. If the protein is to be directed to the nucleus, any signal peptide present should be removed and instead a nuclear localization signal included (Raikhel (1992) Plant Phys. 100:1627-1632).

[0058] “Transformation” refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as “transgenic” organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:277) and particle-accelerated or “gene gun” transformation technology (Klein et al. (1987) Nature (London) 327:70-73; U.S. Pat. No. 4,945,050, incorporated herein by reference).

[0059] Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described more fully in Sambrook et al. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter “Maniatis”).

[0060] Nucleic acid fragments encoding at least a portion of several aminoacyl-tRNA synthetases have been isolated and identified by comparison of random plant cDNA sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art. The nucleic acid fragments of the instant invention may be used to isolate cDNAs and genes encoding homologous proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction).

[0061] For example, genes encoding other seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptides, either as cDNAs or genomic DNAs, could be isolated directly by using all or a portion of the instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant employing methodology well known to those skilled in the art. Specific oligonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Maniatis). Moreover, the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems. In addition, specific primers can be designed and used to amplify a part or all of the instant sequences. The resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency.

[0062] In addition, two short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA. The polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence of the other primer takes advantage of the presence of the polyadenylic acid tracts to the 3′ end of the mRNA precursor encoding plant genes. Alternatively, the second primer sequence may be based upon sequences derived from the cloning vector. For example, the skilled artisan can follow the RACE protocol (Frohman et al. (1988) Proc. Natl. Acad. Sci. USA 85:8998-9002) to generate cDNAs by using PCR to amplify copies of the region between a single point in the transcript and the 3′ or 5′ end. Primers oriented in the 3′ and 5′ directions can be designed from the instant sequences. Using commercially available 3′ RACE or 5′ RACE systems (BRL), specific 3′ or 5′ cDNA fragments can be isolated (Ohara et al. (1989) Proc. Natl. Acad. Sci. USA 86:5673-5677; Loh et al. (1989) Science 243:217-220). Products generated by the 3′ and 5′ RACE procedures can be combined to generate full-length cDNAs (Frohman and Martin (1989) Techniques 1:165). Consequently, a polynucleotide comprising a nucleotide sequence of at least one of 60 (preferably one of at least 40, most preferably one of at least 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 and 27 and the complement of such nucleotide sequences may be used in such methods to obtain a nucleic acid fragment encoding a substantial portion of an amino acid sequence of a polypeptide. The present invention relates to a method of obtaining a nucleic acid fragment encoding a substantial portion of a polypeptide of a gene (such as seryl-tRNA synthetase or threonyl-tRNA synthetase polypeptide) preferably a substantial portion of a plant polypeptide of a gene, comprising the steps of: synthesizing an oligonucleotide primer comprising a nucleotide sequence of at least one of 60 (preferably at least one of 40, most preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 23, 25 and 27 and the complement of such nucleotide sequences; and amplifying a nucleic acid fragment (preferably a cDNA inserted in a cloning vector) using the oligonucleotide primer. The amplified nucleic acid fragment preferably will encode a portion of a polypeptide (such as aminoacyl-tRNA synthetase polypeptide).

[0063] Availability of the instant nucleotide and deduced amino acid sequences facilitates immunological screening of cDNA expression libraries. Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner (1984) Adv. Immunol. 36:1-34; Maniatis).

[0064] The nucleic acid fragments of the instant invention may be used to create transgenic plants in which the disclosed polypeptides are present at higher or lower levels than normal or in cell types or developmental stages in which they are not normally found. This would have the effect of altering the level of aminoacyl-tRNA synthetase in those cells.

[0065] Overexpression of the proteins of the instant invention may be accomplished by first constructing a chimeric gene in which the coding region is operably linked to a promoter capable of directing expression of a gene in the desired tissues at the desired stage of development. For reasons of convenience, the chimeric gene may comprise promoter sequences and translation leader sequences derived from the same genes. 3′ Non-coding sequences encoding transcription termination signals may also be provided. The instant chimeric gene may also comprise one or more introns in order to facilitate gene expression.

[0066] Plasmid vectors comprising the instant chimeric gene can then be constructed. The choice of plasmid vector is dependent upon the method that will be used to transform host plants. The skilled artisan is well aware of the genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al. (1985) EMBO J. 4:2411-2418; De Almeida et al. (1989) Mol. Gen. Genetics 218:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression, Western analysis of protein expression, or phenotypic analysis.

[0067] For some applications it may be useful to direct the instant polypeptides to different cellular compartments, or to facilitate its secretion from the cell. It is thus envisioned that the chimeric gene described above may be further supplemented by altering the coding sequence to encode the instant polypeptides with appropriate intracellular targeting sequences such as transit sequences (Keegstra (1989) Cell 56:247-253), signal sequences or sequences encoding endoplasmic reticulum localization (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53), or nuclear localization signals (Raikhel (1992) Plant Phys. 100:1627-1632) added and/or with targeting sequences that are already present removed. While the references cited give examples of each of these, the list is not exhaustive and more targeting signals of utility may be discovered in the future.

[0068] It may also be desirable to reduce or eliminate expression of genes encoding the instant polypeptides in plants for some applications. In order to accomplish this, a chimeric gene designed for co-suppression of the instant polypeptide can be constructed by linking a gene or gene fragment encoding that polypeptide to plant promoter sequences. Alternatively, a chimeric gene designed to express antisense RNA for all or part of the instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated.

[0069] Molecular genetic solutions to the generation of plants with altered gene expression have a decided advantage over more traditional plant breeding approaches. Changes in plant phenotypes can be produced by specifically inhibiting expression of one or more genes by antisense inhibition or cosuppression (U.S. Pat. Nos. 5,190,931, 5,107,065 and 5,283,323). An antisense or cosuppression construct would act as a dominant negative regulator of gene activity. While conventional mutations can yield negative regulation of gene activity these effects are most likely recessive. The dominant negative regulation available with a transgenic approach may be advantageous from a breeding perspective. In addition, the ability to restrict the expression of specific phenotype to the reproductive tissues of the plant by the use of tissue specific promoters may confer agronomic advantages relative to conventional mutations which may have an effect in all tissues in which a mutant gene is ordinarily expressed.

[0070] The person skilled in the art will know that special considerations are associated with the use of antisense or cosuppression technologies in order to reduce expression of particular genes. For example, the proper level of expression of sense or antisense genes may require the use of different chimeric genes utilizing different regulatory elements known to the skilled artisan. Once transgenic plants are obtained by one of the methods described above, it will be necessary to screen individual transgenics for those that most effectively display the desired phenotype. Accordingly, the skilled artisan will develop methods for screening large numbers of transformants. The nature of these screens will generally be chosen on practical grounds, and is not an inherent part of the invention. For example, one can screen by looking for changes in gene expression by using antibodies specific for the protein encoded by the gene being suppressed, or one could establish assays that specifically measure enzyme activity. A preferred method will be one which allows large numbers of samples to be processed rapidly, since it will be expected that a large number of transformants will be negative for the desired phenotype.

[0071] The instant polypeptides (or portions thereof) may be produced in heterologous host cells, particularly in the cells of microbial hosts, and can be used to prepare antibodies to the these proteins by methods well known to those skilled in the art. The antibodies are useful for detecting the polypeptides of the instant invention in situ in cells or in vitro in cell extracts. Preferred heterologous host cells for production of the instant polypeptides are microbial hosts. Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art. Any of these could be used to construct a chimeric gene for production of the instant polypeptides. This chimeric gene could then be introduced into appropriate microorganisms via transformation to provide high level expression of the encoded aminoacyl-tRNA synthetase. An example of a vector for high level expression of the instant polypeptides in a bacterial host is provided (Example 7).

[0072] Additionally, the instant polypeptides can be used as a targets to facilitate design and/or identification of inhibitors of those enzymes that may be useful as herbicides. This is desirable because the polypeptides described herein catalyze various steps in aminoacyl-tRNA biosynthesis. Accordingly, inhibition of the activity of one or more of the enzymes described herein could lead to inhibition of plant growth. Thus, the instant polypeptides could be appropriate for new herbicide discovery and design.

[0073] All or a substantial portion of the nucleic acid fragments of the instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. For example, the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Maniatis) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments of the instant invention. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1:174-181) in order to construct a genetic map. In addition, the nucleic acid fragments of the instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the instant nucleic acid sequence in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331).

[0074] The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4:37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art.

[0075] Nucleic acid probes derived from the instant nucleic acid sequences may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Nonmammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein).

[0076] In another embodiment, nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favor use of large clones (several to several hundred KB; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes.

[0077] A variety of nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid fragment is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods.

[0078] Loss of function mutant phenotypes may be identified for the instant cDNA clones either by targeted gene disruption protocols or by identifying specific mutants for these genes contained in a maize population carrying mutations in all possible genes (Ballinger and Benzer (1989) Proc. Natl. Acad. Sci USA 86:9402-9406; Koes et al. (1995) Proc. Natl. Acad. Sci USA 92:8149-8153; Bensen et al. (1995) Plant Cell 7:75-84). The latter approach may be accomplished in two ways. First, short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on DNAs prepared from a population of plants in which Mutator transposons or some other mutation-causing DNA element has been introduced (see Bensen, supra). The amplification of a specific DNA fragment with these primers indicates the insertion of the mutation tag element in or near the plant gene encoding the instant polypeptides. Alternatively, the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site-anchored synthetic adaptor. With either method, a plant containing a mutation in the endogenous gene encoding the instant polypeptides can be identified and obtained. This mutant plant can then be used to determine or confirm the natural function of the instant polypeptides disclosed herein.

EXAMPLES

[0079] The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

Example 1 Composition of cDNA Libraries, Isolation and Sequencing of cDNA Clones

[0080] cDNA libraries representing mRNAs from various corn, rice, soybean and wheat tissues were prepared. The characteristics of the libraries are described below. TABLE 2 cDNA Libraries from Corn, Rice, Soybean and Wheat Library Tissue Clone cr1n Corn Root From 7 Day Old Seedlings* cr1n.pk0140.b10 p0017 Corn Ear Shoot, Prophase I (2.8-4.8 cm) p0017.cespf50r res1c Rice Etiolated Seedling res1c.pk005.j13 r1r6 Rice Leaf 15 Days After Germination, 6 Hours After r1r6.pk0084.e1 Infection of Magaporthe grisea Strain 4360-R-62 (AVR2-YAMO); Resistant r1r6.pk0023.e9 s12 Soybean Two-Week-Old Developing Seedlings Treated s12.pk123.g22 With 2.5 ppm chlorimuron srr1c Soybean 8-Day-Old Root srr1c.pk003.k12 w1m4 Wheat Seedlings 4 Hours After Inoculation With Erysiphe w1m4.pk008.d5 graminis f. sp tritici w1m96 Wheat Seedlings 96 Hours After Inoculation With w1m96.pk060.l13 Erysiphe graminis f. sp tritici wr1 Wheat Root From 7 Day Old Seedling wr1.pk181.e1

[0081] cDNA libraries may be prepared by any one of many methods available. For example, the cDNAs may be introduced into plasmid vectors by first preparing the cDNA libraries in Uni-ZAP™ XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, Calif.). The Uni-ZAP™ XR libraries are converted into plasmid libraries according to the protocol provided by Stratagene. Upon conversion, cDNA inserts will be contained in the plasmid vector pBluescript. In addition, the cDNAs may be introduced directly into precut Bluescript II SK(+) vectors (Stratagene) using T4 DNA ligase (New England Biolabs), followed by transfection into DH10B cells according to the manufacturer's protocol (GIBCO BRL Products). Once the cDNA inserts are in plasmid vectors, plasmid DNAs are prepared from randomly picked bacterial colonies containing recombinant pBluescript plasmids, or the insert cDNA sequences are amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences. Amplified insert DNAs or plasmid DNAs are sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or “ESTs”; see Adams et al., (1991) Science 252:1651-1656). The resulting ESTs are analyzed using a Perkin Elmer Model 377 fluorescent sequencer.

Example 2 Identification of cDNA Clones

[0082] cDNA clones encoding aminoacyl-tRNA synthetases were identified by conducting BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol. Biol. 215:403-410; see also wwwv.nebi.nlm.nih.gov/BLAST/) searches for similarity to sequences contained in the BLAST “nr” database (comprising all non-redundant GenBank CDS translations, sequences derived from the 3-dimensional structure Brookhaven Protein Data Bank, the last major release of the SWISS-PROT protein sequence database, EMBL, and DDBJ databases). The cDNA sequences obtained in Example 1 were analyzed for similarity to all publicly available DNA sequences contained in the “nr” database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI). The DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the “nr” database using the BLASTX algorithm (Gish and States (1993) Nat. Genet. 3:266-272) provided by the NCBI. For convenience, the P-value (probability) of observing a match of a cDNA sequence to a sequence contained in the searched databases merely by chance as calculated by BLAST are reported herein as “pLog” values, which represent the negative of the logarithm of the reported P-value. Accordingly, the greater the pLog value, the greater the likelihood that the cDNA sequence and the BLAST “hit” represent homologous proteins.

Example 3 Characterization of cDNA Clones Encoding Seryl-tRNA Synthetase

[0083] The BLASTX search using the EST sequences from clones listed in Table 3 revealed similarity of the polypeptides encoded by the cDNAs to seryl-tRNA synthetase from Zea mays (NCBI Identifier No. gi 3319776) and Arabidopsis thaliana (NCBI Identifier No. gi 2501056). Shown in Table 3 are the BLAST results for individual ESTs (“EST”), the sequences of the entire cDNA inserts comprising the indicated cDNA clones (“FIS”), contigs assembled from two or more ESTs (“Contig”), contigs assembled from an FIS and one or more ESTs (“Contig*”), or sequences encoding the entire protein derived from an FIS, a contig, or an FIS and PCR (“CGS”): TABLE 3 BLAST Results for Sequences Encoding Polypeptides Homologous to Zea mays and Arabidopsis thaliana Sery1-tRNA Synthetase Clone Status BLAST pLog Score r1r6.pk0023.e9 CGS >254.00 (gi 3319776) s12.pk123.g22 FIS    51.00 (gi 2501056) w1m4.pk0018.d5 CGS >254.00 (gi 3319776)

[0084] The data in Table 4 represents a calculation of the percent identity of the amino acid sequences set forth in SEQ ID NOs:16, 18 and 20 and the Zea mays and Arabidopsis thaliana sequences. TABLE 4 Percent Identity of Amino Acid Sequences Deduced From the Nucleotide Sequences of cDNA Clones Encoding Polypeptides Homologous to Zea mays and Arabidoesis thaliana Seryl-tRNA Synthetase SEQ ID NO. Percent Identity to 16 75% (gi 3319776) 18 80% (gi 2501056) 20 80% (gi 3319776)

[0085] Sequence alignments and percent identity calculations were performed using the Megalign program of the LASERGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5. Sequence alignments and BLAST scores and probabilities indicate that the nucleic acid fragments comprising the instant cDNA clones encode a substantial portion of a seryl-tRNA synthetase. These sequences represent the first rice, soybean and wheat sequences encoding seryl-tRNA synthetase.

Example 4 Characterization of cDNA Clones Encoding Threonyl-tRNA Synthetase

[0086] The BLASTX search using the EST sequences from clones listed in Table 5 revealed similarity of the polypeptides encoded by the cDNAs to threonyl-tRNA synthetase from Arabidopsis thaliana (NCBI Identifier No. gi 3617770). Shown in Table 5 are the BLAST results for individual ESTs (“EST”), the sequences of the entire cDNA inserts comprising the indicated cDNA clones (“FIS”), contigs assembled from two or more ESTs (“Contig”), contigs assembled from an FIS and one or more ESTs (“Contig*”), or sequences encoding the entire protein derived from an FIS, a contig, or an FIS and PCR (“CGS”): TABLE 5 BLAST Results for Sequences Encoding Polypeptides Homologous to Arabidopis thaliana Threonyl-t-RNA Synthetase Clone Status BLAST pLog Score to gi 3617770 p0017.cespf50r FIS >254.00 res1c.pk005.j13 FIS >254.00 srr1c.pk003.k12 FIS >254.00 w1m96.pk060.l13 FIS >254.00

[0087] The data in Table 6 represents a calculation of the percent identity of the amino acid sequences set forth in SEQ ID NOs:22, 24, 26 and 28 and the Arabidopsis thaliana sequence. TABLE 6 Percent Identity of Amino Acid Sequences Deduced From the Nucleotide Sequences of cDNA Clones Encoding Polypeptides Homologous to\ Arabidopsis thaliana Threonyl-tRNA Synthetase SEQ ID NO. Percent Identity to 22 66% 24 73% 26 76% 28 76%

[0088] Sequence alignments and percent identity calculations were performed using the Megalign program of the LASERGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5. Sequence alignments and BLAST scores and probabilities indicate that the nucleic acid fragments comprising the instant cDNA clones encode a substantial portion of a threonyl-tRNA synthetase. These sequences represent the first corn, rice, soybean and wheatsequences encoding threonyl-tRNA synthetase.

Example 5 Expression of Chimeric Genes in Monocot Cells

[0089] A chimeric gene comprising a cDNA encoding the instant polypeptide in sense orientation with respect to the maize 27 kD zein promoter that is located 5′ to the cDNA fragment, and the 10 kD zein 3′ end that is located 3′ to the cDNA fragment, can be constructed. The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites (NcoI or SmaI) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below. Amplification is then performed in a standard PCR. The amplified DNA is then digested with restriction enzymes NcoI and SmaI and fractionated on an agarose gel. The appropriate band can be isolated from the gel and combined with a 4.9 kb NcoI-SmaI fragment of the plasmid pML103. Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Blvd., Manassas, Va. 20110-2209), and bears accession number ATCC 97366. The DNA segment from pML103 contains a 1.05 kb SalI-NcoI promoter fragment of the maize 27 kD zein gene and a 0.96 kb SmaI-SalI fragment from the 3′ end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at 15° C. overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XL1-Blue (Epicurian Coli XL-1 Blue™; Stratagene). Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (Sequenase™ DNA Sequencing Kit; U.S. Biochemical). The resulting plasmid construct would comprise a chimeric gene encoding, in the 5′ to 3′ direction, the maize 27 kD zein promoter, a cDNA fragment encoding the instant polypeptides, and the 10 kD zein 3′ region.

[0090] The chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132. The embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long. The embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al. (1975) Sci. Sin. Peking 18:659-668). The embryos are kept in the dark at 27° C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos. The embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks.

[0091] The plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst Ag, Frankfurt, Germany) may be used in transformation experiments in order to provide for a selectable marker. This plasmid contains the Pat gene (see European Patent Publication 0 242 236) which encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin. The pat gene in p35S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.

[0092] The particle bombardment method (Klein et al. (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells. According to this method, gold particles (1 μm in diameter) are coated with DNA using the following technique. Ten μg of plasmid DNAs are added to 50 μ

of a suspension of gold particles (60 mg per m

). Calcium chloride (50 μ

of a 2.5 M solution) and spermidine free base (20 μ

of a 1.0 M solution) are added to the particles. The suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed. The particles are resuspended in 200 μ

of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 μ

of ethanol. An aliquot (5 μ

) of the DNA-coated gold particles can be placed in the center of a Kapton™ flying disc (Bio-Rad Labs). The particles are then accelerated into the corn tissue with a Biolistic™ PDS-1000/He (Bio-Rad Instruments, Hercules Calif.), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm.

[0093] For bombardment, the embryogenic tissue is placed on filter paper over agarose-solidified N6 medium. The tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter. The petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen. The air in the chamber is then evacuated to a vacuum of 28 inches of Hg. The macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi.

[0094] Seven days after bombardment the tissue can be transferred to N6 medium that contains gluphosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium. After an additional 2 weeks the tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the glufosinate-supplemented medium. These calli may continue to grow when sub-cultured on the selective medium.

[0095] Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al. (1990) Bio/Technology 8:833-839).

Example 6 Expression of Chimeric Genes in Dicot Cells

[0096] A seed-specific expression cassette composed of the promoter and transcription terminator from the gene encoding the β subunit of the seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem. 261:9228-9238) can be used for expression of the instant polypeptides in transformed soybean. The phaseolin cassette includes about 500 nucleotides upstream (5′) from the translation initiation codon and about 1650 nucleotides downstream (3′) from the translation stop codon of phaseolin. Between the 5′ and 3′ regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Sma I, Kpn I and Xba I. The entire cassette is flanked by Hind III sites.

[0097] The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette.

[0098] Soybean embryos may then be transformed with the expression vector comprising sequences encoding the instant polypeptides. To induce somatic embryos, cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26° C. on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below.

[0099] Soybean embryogenic suspension cultures can maintained in 35 m

liquid media on a rotary shaker, 150 rpm, at 26° C. with florescent lights on a 16:8 hour day/night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 m

of liquid medium.

[0100] Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Klein et al. (1987) Nature (London) 327:70-73, U.S. Pat. No. 4,945,050). A DuPont Biolistic™ PDS 1000/HE instrument (helium retrofit) can be used for these transformations.

[0101] A selectable marker gene which can be used to facilitate soybean transformation is a chimeric gene composed of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al.(1983) Gene 25:179-188) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens. The seed expression cassette comprising the phaseolin 5′ region, the fragment encoding the instant polypeptides and the phaseolin 3′ region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene.

[0102] To 50 μL of a 60 mg/m

1 μm gold particle suspension is added (in order): 5 μ

DNA (1 μg/μ

), 20 μl spermidine (0.1 M), and 50 μ

CaCl₂ (2.5 M). The particle preparation is then agitated for three minutes, spun in a microfuge for 10 seconds and the supernatant removed. The DNA-coated particles are then washed once in 400 μ

70% ethanol and resuspended in 40 μ

of anhydrous ethanol. The DNA/particle suspension can be sonicated three times for one second each. Five μ

of the DNA-coated gold particles are then loaded on each macro carrier disk.

[0103] Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60×15 mm petri dish and the residual liquid removed from the tissue with a pipette. For each transformation experiment, approximately 5-10 plates of tissue are normally bombarded. Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury. The tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above.

[0104] Five to seven days post bombardment, the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/m

hygromycin. This selective media can be refreshed weekly. Seven to eight weeks post bombardment, green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos.

Example 7 Expression of Chimeric Genes in Microbial Cells

[0105] The cDNAs encoding the instant polypeptides can be inserted into the T7 E. coli expression vector pBT430. This vector is a derivative of pET-3a (Rosenberg et al. (1987) Gene 56:125-135) which employs the bacteriophage T7 RNA polymerase/T7 promoter system. Plasmid pBT430 was constructed by first destroying the EcoR I and Hind III sites in pET-3a at their original positions. An oligonucleotide adaptor containing EcoR I and Hind III sites was inserted at the BamH I site of pET-3a. This created pET-3aM with additional unique cloning sites for insertion of genes into the expression vector. Then, the Nde I site at the position of translation initiation was converted to an Nco I site using oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM in this region, 5′-CATATGG, was converted to 5′-CCCATGG in pBT430.

[0106] Plasmid DNA containing a cDNA may be appropriately digested to release a nucleic acid fragment encoding the protein. This fragment may then be purified on a 1% NuSieve GTG™ low melting agarose gel (FMC). Buffer and agarose contain 10 μg/ml ethidium bromide for visualization of the DNA fragment. The fragment can then be purified from the agarose gel by digestion with GELase™ (Epicentre Technologies) according to the manufacturer's instructions, ethanol precipitated, dried and resuspended in 20 μ

of water. Appropriate oligonucleotide adapters may be ligated to the fragment using T4 DNA ligase (New England Biolabs, Beverly, Mass.). The fragment containing the ligated adapters can be purified from the excess adapters using low melting agarose as described above. The vector pBT430 is digested, dephosphorylated with alkaline phosphatase (NEB) and deproteinized with phenol/chloroform as described above. The prepared vector pBT430 and fragment can then be ligated at 16° C. for 15 hours followed by transformation into DH5 electrocompetent cells (GIBCO BRL). Transformants can be selected on agar plates containing LB media and 100 μg/m

ampicillin. Transformants containing the gene encoding the instant polypeptides are then screened for the correct orientation with respect to the T7 promoter by restriction enzyme analysis.

[0107] For high level expression, a plasmid clone with the cDNA insert in the correct orientation relative to the T7 promoter can be transformed into E. coli strain BL21(DE3) (Studier et al. (1986) J. Mol. Biol. 189:113-130). Cultures are grown in LB medium containing ampicillin (100 mg/L) at 25° C. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio-β-galactoside, the inducer) can be added to a final concentration of 0.4 mM and incubation can be continued for 3 h at 25°. Cells are then harvested by centrifugation and re-suspended in 50 μ

of 50 mM Tris-HCl at pH 8.0 containing 0.1 mM DTT and 0.2 mM phenyl methylsulfonyl fluoride. A small amount of 1 mm glass beads can be added and the mixture sonicated 3 times for about 5 seconds each time with a microprobe sonicator. The mixture is centrifuged and the protein concentration of the supernatant determined. One μg of protein from the soluble fraction of the culture can be separated by SDS-polyacrylamide gel electrophoresis. Gels can be observed for protein bands migrating at the expected molecular weight.

Example 8 Evaluating Compounds for Their Ability to Inhibit the Activity of Aminoacyl-tRNA Synthetases

[0108] The polypeptides described herein may be produced using any number of methods known to those skilled in the art. Such methods include, but are not limited to, expression in bacteria as described in Example 7, or expression in eukaryotic cell culture, in planta, and using viral expression systems in suitably infected organisms or cell lines. The instant polypeptides may be expressed either as mature forms of the proteins as observed in vivo or as fusion proteins by covalent attachment to a variety of enzymes, proteins or affinity tags. Common fusion protein partners include glutathione S-transferase (“GST”), thioredoxin (“Trx”), maltose binding protein, and C- and/or N-terminal hexahistidine polypeptide (“(His)₆”). The fusion proteins may be engineered with a protease recognition site at the fusion point so that fusion partners can be separated by protease digestion to yield intact mature enzyme. Examples of such proteases include thrombin, enterokinase and factor Xa. However, any protease can be used which specifically cleaves the peptide connecting the fusion protein and the enzyme.

[0109] Purification of the instant polypeptides, if desired, may utilize any number of separation technologies familiar to those skilled in the art of protein purification. Examples of such methods include, but are not limited to, homogenization, filtration, centrifugation, heat denaturation, ammonium sulfate precipitation, desalting, pH precipitation, ion exchange chromatography, hydrophobic interaction chromatography and affinity chromatography, wherein the affinity ligand represents a substrate, substrate analog or inhibitor. When the instant polypeptides are expressed as fusion proteins, the purification protocol may include the use of an affinity resin which is specific for the fusion protein tag attached to the expressed enzyme or an affinity resin containing ligands which are specific for the enzyme. For example, the instant polypeptides may be expressed as a fusion protein coupled to the C-terminus of thioredoxin. In addition, a (His)₆ peptide may be engineered into the N-terminus of the fused thioredoxin moiety to afford additional opportunities for affinity purification. Other suitable affinity resins could be synthesized by linking the appropriate ligands to any suitable resin such as Sepharose-4B. In an alternate embodiment, a thioredoxin fusion protein may be eluted using dithiothreitol; however, elution may be accomplished using other reagents which interact to displace the thioredoxin from the resin. These reagents include β-mercaptoethanol or other reduced thiol. The eluted fusion protein may be subjected to further purification by traditional means as stated above, if desired. Proteolytic cleavage of the thioredoxin fusion protein and the enzyme may be accomplished after the fusion protein is purified or while the protein is still bound to the ThioBond™ affinity resin or other resin.

[0110] Crude, partially purified or purified enzyme, either alone or as a fusion protein, may be utilized in assays for the evaluation of compounds for their ability to inhibit enzymatic activation of the instant polypeptides disclosed herein. Assays may be conducted under well known experimental conditions which permit optimal enzymatic activity. For example, assays for aminoacyl-tRNA synthetase activity are presented by (Lloyd et al., (1995) Nucleic Acid Research 23(15):2882-2892).

1 28 1 562 DNA Oryza sp. unsure (431) n = a, c, g or t 1 gtttaaactc tacccttccc tctctgctcg ccgccgccgc cgccgccgca cgccttcgaa 60 gatgctcgac atcaacctct tccgcacgga gaagggcggc gacccggagc tgatccgcag 120 gtcgcagcgc aaccgctccg cctccgtcga gctcgtcgac gaggtcatcg ccctcgacga 180 ccagtggcgc cagaggcaat tcgagctcga caaaatccgg caggagctca acaaaaccag 240 caaggaaatc ggcaagctca aggctaaaaa ggaggacgcg tcggctctga ttcagagcac 300 ggaagagatt aagaagaggt tggctgccaa ggagacggag gtgcaggaag ccaagggcac 360 gctcgatgcc aagctcgtga cgattggaaa cattgtgcat gaatccgtcc ctgtcagcga 420 tgacgaggct ncaatttaat tgtacggaca tggggaagag aggctggagg aatttgaaga 480 nacgtggatt tngaaatntt acatagagct tgagangtnt ntgatcangt gaanggtaca 540 ttaatganna gggccactga ct 562 2 125 PRT Oryza sp. UNSURE (124) Xaa = any amino acid 2 Met Leu Asp Ile Asn Leu Phe Arg Thr Glu Lys Gly Gly Asp Pro Glu 1 5 10 15 Leu Ile Arg Arg Ser Gln Arg Asn Arg Ser Ala Ser Val Glu Leu Val 20 25 30 Asp Glu Val Ile Ala Leu Asp Asp Gln Trp Arg Gln Arg Gln Phe Glu 35 40 45 Leu Asp Lys Ile Arg Gln Glu Leu Asn Lys Thr Ser Lys Glu Ile Gly 50 55 60 Lys Leu Lys Ala Lys Lys Glu Asp Ala Ser Ala Leu Ile Gln Ser Thr 65 70 75 80 Glu Glu Ile Lys Lys Arg Leu Ala Ala Lys Glu Thr Glu Val Gln Glu 85 90 95 Ala Lys Gly Thr Leu Asp Ala Lys Leu Val Thr Ile Gly Asn Ile Val 100 105 110 His Glu Ser Val Pro Val Ser Asp Asp Glu Ala Xaa Ile 115 120 125 3 489 DNA Glycine max 3 atgatgctgc agcaaagaag tatgatctag aagcatggtt tccagcctct caagcttaca 60 gagagctagt gtcctgttca aactgtacag actatcaggc cagaagatta gaaattcgat 120 atggtcagaa aaagagcaat gagcaaatga agcaatatgt tcacttgttg aactctactc 180 taacggctac tgagaggacc atttgctgca tactagagaa caaccagaag gaagatgggg 240 tagagatacc agaagccctc aggccattca tgggtggaaa gactttccta cctttcaaga 300 accaaccatc taatgaagcc aaagggaaga aatcgaaggc ctaattgcat tttaagtcag 360 tgatatttat gaagagtttg ttcagagttg taggttatga tgaccccgat attatccacc 420 acacactgtt tccctttctc actaaatagt aaaatgattt ttaggagcac gcaccatttt 480 tgggtcaaa 489 4 102 PRT Glycine max 4 Asp Ala Ala Ala Lys Lys Tyr Asp Leu Glu Ala Trp Phe Pro Ala Ser 1 5 10 15 Gln Ala Tyr Arg Glu Leu Val Ser Cys Ser Asn Cys Thr Asp Tyr Gln 20 25 30 Ala Arg Arg Leu Glu Ile Arg Tyr Gly Gln Lys Lys Ser Asn Glu Gln 35 40 45 Met Lys Gln Tyr Val His Leu Leu Asn Ser Thr Leu Thr Ala Thr Glu 50 55 60 Arg Thr Ile Cys Cys Ile Leu Glu Asn Asn Gln Lys Glu Asp Gly Val 65 70 75 80 Glu Ile Pro Glu Ala Leu Arg Pro Phe Met Gly Gly Lys Thr Phe Leu 85 90 95 Pro Phe Lys Asn Gln Pro 100 5 641 DNA Triticum sp. unsure (354) n = a, c, g or t 5 ccgtcatcca cctctcgtca gaagaaccct ccctctccgc cctccgccgc cgccgccgcc 60 gccgccaatc gcagcgcagc cgcctcgccc ccgtcgagct cgtccgcgga gaagttggcc 120 tagccgcggt cgcacgagaa tatgctcgac atcaacctct tccgcaagga gaagggcggc 180 gaccctgagc tcgtccgcca gtcgcagcgc agccgcttcg cccccgtcga gctcgtcgac 240 gaggtcatcg tcctcgacga ggcgtggcgc cagaggcagt tcgagctcga caagatccgg 300 caggagctca acaaaaccag caaggagatc ggcaagctca aggccaaaaa gcangatgcg 360 acggagctga tacagagcac ggagggagat taagaagagg ctggccgcca aggagacgga 420 cgtncaggag gcaagacacc tcgatgcaag ctagttacat cggcaactcg tgcatgatct 480 gnccataaca acgacgagca aacatctttg ncggcatggg caanaaanat ggggagaatn 540 aagatcagtg gtnctnnaaa tgctgnanct ancttgaaag gnctagttct gggaaaggtn 600 ntttaaggga nggttccnaa cangttaaaa tttggcatat n 641 6 81 PRT Triticum sp. UNSURE (71) Xaa = any amino acid 6 Met Leu Asp Ile Asn Leu Phe Arg Lys Glu Lys Gly Gly Asp Pro Glu 1 5 10 15 Leu Val Arg Gln Ser Gln Arg Ser Arg Phe Ala Pro Val Glu Leu Val 20 25 30 Asp Glu Val Ile Val Leu Asp Glu Ala Trp Arg Gln Arg Gln Phe Glu 35 40 45 Leu Asp Lys Ile Arg Gln Glu Leu Asn Lys Thr Ser Lys Glu Ile Gly 50 55 60 Lys Leu Lys Ala Lys Lys Xaa Asp Ala Thr Glu Leu Ile Gln Ser Thr 65 70 75 80 Glu 7 536 DNA Zea mays unsure (333) n = a, c, g or t 7 gaaacttgga acaaagctga gcaacaattg acagaagctt taaatgagtt tgggaagcca 60 tggaagatta atgaagggga tggtgctttc tacggcccaa aaattgatat tggtgtgttt 120 gatgccctta agaggaaatt tcagtgtgca accctacagc tggattttca gctgcccatt 180 cggttcaagc tggcttattc tgctgaggat gaagccaaaa ttgaaaggcc tgtgatgata 240 cacagggcaa tcctaggttc ggttgaaagg atgcttgcca ttcttttggg agcattacaa 300 tggtaaatgg ccttatggct aaccctcgcc agncattgtt tgctcggtac ttctggtcag 360 tggatatgcc aaacaantcc tgccactcca catgaactgg tttcatgttg atattgaccc 420 aatgacanga caatacaaaa gaagnacngg aactcaactg gccaatcaac tacatcctgt 480 cgtagtgcac aanaagcnag acgggaatat atccttaggg aanagaaatc nactgt 536 8 95 PRT Zea mays 8 Glu Thr Trp Asn Lys Ala Glu Gln Gln Leu Thr Glu Ala Leu Asn Glu 1 5 10 15 Phe Gly Lys Pro Trp Lys Ile Asn Glu Gly Asp Gly Ala Phe Tyr Gly 20 25 30 Pro Lys Ile Asp Ile Gly Val Phe Asp Ala Leu Lys Arg Lys Phe Gln 35 40 45 Cys Ala Thr Leu Gln Leu Asp Phe Gln Leu Pro Ile Arg Phe Lys Leu 50 55 60 Ala Tyr Ser Ala Glu Asp Glu Ala Lys Ile Glu Arg Pro Val Met Ile 65 70 75 80 His Arg Ala Ile Leu Gly Ser Val Glu Arg Met Leu Ala Ile Leu 85 90 95 9 425 DNA Oryza sp. unsure (249) n = a, c, g or t 9 gtttaaacga ttcatagagc tatccttggg tctttggaac gattttttgg tgtcctcatt 60 gaacactatg ctggtgattt tccactttgg cttgcaccaa tccaagctcg tattctacct 120 gtgacagaca atgagctgca atactgtaac gaggtggctt cagaactgaa atcaaaaggc 180 attccgagct gaggtatgtc atggcgagcg tctaccaaag ctaatacgga atgcccgaaa 240 cgaagaaant gccgctcatg ggcggccttg gggcctaaag aantcnaagc aaggaccctc 300 cactacaggc caagcatagt ggggaattgg gactatgcct gtgggatgat tccttcgcag 360 aaccaacttg ctattggcga acaacctcct caactaatga acatttaaat atgctaaaga 420 cagtt 425 10 58 PRT Oryza sp. 10 Ile His Arg Ala Ile Leu Gly Ser Leu Glu Arg Phe Phe Gly Val Leu 1 5 10 15 Ile Glu His Tyr Ala Gly Asp Phe Pro Leu Trp Leu Ala Pro Ile Gln 20 25 30 Ala Arg Ile Leu Pro Val Thr Asp Asn Glu Leu Gln Tyr Cys Asn Glu 35 40 45 Val Ala Ser Glu Leu Lys Ser Lys Gly Ile 50 55 11 508 DNA Glycine max unsure (467) n = a, c, g or t 11 acactatgct atgctatgct ctctaatccg tttccgccgt tacgctcctt cctaccgcac 60 tctccactct ctctttccga cgattaaccg tttctcctcc tccgtctcct ccgcctccgc 120 cgccatggtt gctcacgcga aggacgaggc gtacctcagc gcgacgattc cgaaacgcat 180 ccgtctcttc gagaccatcc tggcggagca gcacactcag cgcctctcgc tctccccgga 240 tcctatcaag gttactctcc ccgacggcag cgtcaaggag gcgaagaagt ggcatacgac 300 gccgcttgat gttgcgcgtg aaatctcgaa gaatttggcc aacagcgcgc tcatcgcgaa 360 ggtcaatggc gtgctctggg acatgactcg ccctctcgag gacgattgcc aagctccaga 420 tcttcaagtt cgacgacgac gaaggccgcg acaccttctg ggactcnagc gcccacattc 480 tcgggcaagt cacttgagac ggatatgg 508 12 80 PRT Glycine max 12 Ile Pro Lys Arg Ile Arg Leu Phe Glu Thr Ile Leu Ala Glu Gln His 1 5 10 15 Thr Gln Arg Leu Ser Leu Ser Pro Asp Pro Ile Lys Val Thr Leu Pro 20 25 30 Asp Gly Ser Val Lys Glu Ala Lys Lys Trp His Thr Thr Pro Leu Asp 35 40 45 Val Ala Arg Glu Ile Ser Lys Asn Leu Ala Asn Ser Ala Leu Ile Ala 50 55 60 Lys Val Asn Gly Val Leu Trp Asp Met Thr Arg Pro Leu Glu Asp Asp 65 70 75 80 13 487 DNA Triticum sp. unsure (467) n = a, c, g or t 13 gttattaggg cagtcccaga aactcttctt tttccatcca cttagcccag gtagctgctt 60 cttccttcca aatggcgcta taatatataa caaattgatg gattttttgc gcaaggagta 120 tagagagaga ggctaccaag aggttctgag tccaaatatt tacaacatgc aactttggga 180 aacctctgga catgctgcaa actacaagga caacatgttt gtttttgaga tcgagaaaca 240 agaatttggc cttaagccaa tgaattgtcc tggccattgc ctaatgtttg gacacgaggt 300 tcgatcgtat agagagttgc ctctccgcat ggctgatttt gggagttctg cacagaaatg 360 aacttagtgg gtgcacttac aggtttgaca cgtgtcagaa gatccaacag gacgatgccc 420 atattttttg cacggagagc aaatcaagga tgaagttcgg gcttgcntgg gagtcaatga 480 tatgtta 487 14 146 PRT Triticum sp. 14 Leu Gly Gln Ser Gln Lys Leu Phe Phe Phe His Pro Leu Ser Pro Gly 1 5 10 15 Ser Cys Phe Phe Leu Pro Asn Gly Ala Ile Ile Tyr Asn Lys Leu Met 20 25 30 Asp Phe Leu Arg Lys Glu Tyr Arg Glu Arg Gly Tyr Gln Glu Val Leu 35 40 45 Ser Pro Asn Ile Tyr Asn Met Gln Leu Trp Glu Thr Ser Gly His Ala 50 55 60 Ala Asn Tyr Lys Asp Asn Met Phe Val Phe Glu Ile Glu Lys Gln Glu 65 70 75 80 Phe Gly Leu Lys Pro Met Asn Cys Pro Gly His Cys Leu Met Phe Gly 85 90 95 His Glu Val Arg Ser Tyr Arg Glu Leu Pro Leu Arg Met Ala Asp Phe 100 105 110 Gly Val Leu His Arg Asn Glu Leu Ser Gly Cys Thr Tyr Arg Phe Asp 115 120 125 Thr Cys Gln Lys Ile Gln Gln Asp Asp Ala His Ile Phe Cys Thr Glu 130 135 140 Ser Lys 145 15 1753 DNA Oryza sativa 15 gcacgaggtt taaactctac ccttccctct ctgctcgccg ccgccgccgc cgccgcacgc 60 cttcgaagat gctcgacatc aacctcttcc gcacggagaa gggcggcgac ccggagctga 120 tccgcaggtc gcagcgcaac cgctccgcct ccgtcgagct cgtcgacgag gtcatcgccc 180 tcgacgacca gtggcgccag aggcaattcg agctcgacaa aatccggcag gagctcaaca 240 aaaccagcaa ggaaatcggc aagctcaagg ctaaaaagga ggacgcgtcg gctctgattc 300 agagcacgga agagattaag aagaggttgg ctgccaagga gacggaggtg caggaggcca 360 agggcacgct cgatgccaag ctcgtgacga ttggaaacat tgtgcatgaa tccgtccctg 420 tcagcgatga cgaggctaac aatttaattg tacggacatg gggagagagg aggctggagg 480 gtaatttgaa gaatcacgtg gatctttgta agatgcttga catagtagct ttggagaaag 540 gtgctgatgt agcaggtgga aggggttact atttaaagga tgaaggtgtc ctactgaact 600 tggcattgat aaattttgga ctcgcttttc tgagaaagcg aggcttcaag ccaatgcaaa 660 ctcctttttt catgagaaag gaaaccatgg gaaaatgtgc ccagttggcc caatttgacg 720 aagagcttta caagctaaca ggcgatggag aggaaaagta tctcatcgct acatccgagc 780 aaccgctgtg tgcgtatcat ctaggtgatc gaatttatcc tgctgaattg ccaattagat 840 atgctggata ttccacctgc ttccggaaag aagctggttc acatggaagg gacacggctg 900 gtatcttcag agtccaccaa ttcgaaaaga ttgagcaatt ctgtgttaca agtccaaatg 960 acaatgaatc ctgggagatg catgaagaaa tgataaaaaa ttcagaagat ttctacaagg 1020 agattggcct accgtaccaa cttgtctcca ttgtgtctgg tgctcttaat gatgctgcag 1080 ctaagaagta tgatttagaa gcatggttcc ctgcatcaaa aacctatagg gaattagtgt 1140 cctgctcaaa ttgcacagat tttcaagcaa ggagacttgg tataggttat ggccagaaaa 1200 agaatgatag caatccaagc aattcgttca tatgttgaac tcaacattga ctgccactga 1260 gaggaccctt tgctgtattt tggagaactt ccagaaggag aatggtgtcg aagttccaaa 1320 agcattgcag ccttacatgg gtggaatcga tttccttcct ttcaagctgg atagcaaaca 1380 agttgctcga ctccaaatca aataatccaa attcaaaggg agatgctatc tgagctagat 1440 gaggaatcaa caaagatttt cttgctttca gacactactg gatgttattc atacttctaa 1500 aaaatgcgtt tgttcagaac ttgtatcaat gatcatgatg ttacagtttt ggctctcatt 1560 tgagtgtatt gattagcaca atgtctgacc atgtacttgc acagtgatat tccgtagaat 1620 gtctggctat cttggacatg tgcgcttaat ttgccgtaaa agatgtattc attttcatgg 1680 cctttagtgc ctatactaat ttgttgcata caaaaaaaaa aaaaaaaaaa aaaaaaaaaa 1740 aaaaaaaaaa aaa 1753 16 453 PRT Oryza sativa UNSURE (390) Xaa = any amino acid 16 Met Leu Asp Ile Asn Leu Phe Arg Thr Glu Lys Gly Gly Asp Pro Glu 1 5 10 15 Leu Ile Arg Arg Ser Gln Arg Asn Arg Ser Ala Ser Val Glu Leu Val 20 25 30 Asp Glu Val Ile Ala Leu Asp Asp Gln Trp Arg Gln Arg Gln Phe Glu 35 40 45 Leu Asp Lys Ile Arg Gln Glu Leu Asn Lys Thr Ser Lys Glu Ile Gly 50 55 60 Lys Leu Lys Ala Lys Lys Glu Asp Ala Ser Ala Leu Ile Gln Ser Thr 65 70 75 80 Glu Glu Ile Lys Lys Arg Leu Ala Ala Lys Glu Thr Glu Val Gln Glu 85 90 95 Ala Lys Gly Thr Leu Asp Ala Lys Leu Val Thr Ile Gly Asn Ile Val 100 105 110 His Glu Ser Val Pro Val Ser Asp Asp Glu Ala Asn Asn Leu Ile Val 115 120 125 Arg Thr Trp Gly Glu Arg Arg Leu Glu Gly Asn Leu Lys Asn His Val 130 135 140 Asp Leu Cys Lys Met Leu Asp Ile Val Ala Leu Glu Lys Gly Ala Asp 145 150 155 160 Val Ala Gly Gly Arg Gly Tyr Tyr Leu Lys Asp Glu Gly Val Leu Leu 165 170 175 Asn Leu Ala Leu Ile Asn Phe Gly Leu Ala Phe Leu Arg Lys Arg Gly 180 185 190 Phe Lys Pro Met Gln Thr Pro Phe Phe Met Arg Lys Glu Thr Met Gly 195 200 205 Lys Cys Ala Gln Leu Ala Gln Phe Asp Glu Glu Leu Tyr Lys Leu Thr 210 215 220 Gly Asp Gly Glu Glu Lys Tyr Leu Ile Ala Thr Ser Glu Gln Pro Leu 225 230 235 240 Cys Ala Tyr His Leu Gly Asp Arg Ile Tyr Pro Ala Glu Leu Pro Ile 245 250 255 Arg Tyr Ala Gly Tyr Ser Thr Cys Phe Arg Lys Glu Ala Gly Ser His 260 265 270 Gly Arg Asp Thr Ala Gly Ile Phe Arg Val His Gln Phe Glu Lys Ile 275 280 285 Glu Gln Phe Cys Val Thr Ser Pro Asn Asp Asn Glu Ser Trp Glu Met 290 295 300 His Glu Glu Met Ile Lys Asn Ser Glu Asp Phe Tyr Lys Glu Ile Gly 305 310 315 320 Leu Pro Tyr Gln Leu Val Ser Ile Val Ser Gly Ala Leu Asn Asp Ala 325 330 335 Ala Ala Lys Lys Tyr Asp Leu Glu Ala Trp Phe Pro Ala Ser Lys Thr 340 345 350 Tyr Arg Glu Leu Val Ser Cys Ser Asn Cys Thr Asp Phe Gln Ala Arg 355 360 365 Arg Leu Gly Ile Gly Tyr Gly Gln Lys Lys Asn Asp Ser Asn Pro Ser 370 375 380 Asn Ser Phe Ile Cys Xaa Thr Gln His Xaa Leu Pro Leu Arg Gly Pro 385 390 395 400 Phe Ala Val Phe Trp Arg Thr Ser Arg Arg Arg Met Val Ser Lys Phe 405 410 415 Gln Lys His Cys Ser Leu Thr Trp Val Glu Ser Ile Ser Phe Leu Ser 420 425 430 Ser Trp Ile Ala Asn Lys Leu Leu Asp Ser Lys Ser Asn Asn Pro Asn 435 440 445 Ser Lys Gly Asp Ala 450 17 554 DNA Glycine max 17 cgcacgagat gatgctgcag caaagaagta tgatctagaa gcatggtttc cagcctctca 60 agcttacaga gagctagtgt cctgttcaaa ctgtacagac tatcaggcca gaagattaga 120 aattcgatat ggtcagaaaa agagcaatga gcaaatgaag caatatgttc acttgttgaa 180 ctctactcta acggctactg agaggaccat ttgctgcata ctagagaaca accagaagga 240 agatggggta gagataccag aagccctcag gccattcatg ggtggaaaga ctttcctacc 300 tttcaagaac caaccatcta atgaagccaa agggaagaaa tcgaaggcct aattgcattt 360 taagtcagtg atatttatga agagtttgtt cagagttgta ggttatgatg accccgatat 420 tatccaccac acactgtttc cctttctcac taaatagtaa aatgattttt aggagcacgc 480 accatttttg gtcaaagtac acagcatgac attttctgta attcattact ctaaaaaatt 540 tgtgcttttt taac 554 18 116 PRT Glycine max 18 Ala Arg Asp Asp Ala Ala Ala Lys Lys Tyr Asp Leu Glu Ala Trp Phe 1 5 10 15 Pro Ala Ser Gln Ala Tyr Arg Glu Leu Val Ser Cys Ser Asn Cys Thr 20 25 30 Asp Tyr Gln Ala Arg Arg Leu Glu Ile Arg Tyr Gly Gln Lys Lys Ser 35 40 45 Asn Glu Gln Met Lys Gln Tyr Val His Leu Leu Asn Ser Thr Leu Thr 50 55 60 Ala Thr Glu Arg Thr Ile Cys Cys Ile Leu Glu Asn Asn Gln Lys Glu 65 70 75 80 Asp Gly Val Glu Ile Pro Glu Ala Leu Arg Pro Phe Met Gly Gly Lys 85 90 95 Thr Phe Leu Pro Phe Lys Asn Gln Pro Ser Asn Glu Ala Lys Gly Lys 100 105 110 Lys Ser Lys Ala 115 19 1719 DNA Triticum aestivum 19 ccgtcatcca cctctcgtca gaagaaccct ccctctccgc cctccgccgc cgccgccgcc 60 gccgccaatc gcagcgcagc cgcctcgccc ccgtcgagct cgtccgcgga gaagttggcc 120 tagccgcggt cgcacgagaa tatgctcgac atcaacctct tccgcaagga gaagggcggc 180 gaccctgagc tcgtccgcca gtcgcagcgc agccgcttcg cccccgtcga gctcgtcgac 240 gaggtcatcg tcctcgacga ggcgtggcgc cagaggcagt tcgagctcga caagatccgg 300 caggagctca acaaaaccag caaggagatc ggcaagctca aggccaaaaa gcaggatgcg 360 acggagctga tacagagcac ggaggagatt aagaagaggc tggccgccaa ggagacggac 420 gtgcaggagg ccaagaccac cctcgatgcc aagctagtta ccatcggcaa cctcgtgcat 480 gaatctgtgc ccatcagcaa cgacgaggca aacaatgcta ttgtgcggac atggggcgag 540 aagagactgg aggagaaatt gaagaatcat gtggatcttt gcataatgct tgacatcgta 600 tctttggata agggtgctga tgtagctggt ggaagaggtt tctttttgaa gggtgacggt 660 gttctcctga accaggcgtt gataaatttt gggctatcat tcctgggaaa acgagaattt 720 acaccaatgc aaactccttt tttcatgaga aaggagatca tggcaaaatg tgcccagttg 780 gcccaatttg atgaggagct ctacaaagta acaggtgacg gagaggataa gtatctcata 840 gcaacatcgg agcaaccgct atgtgcttat catctaggtg atcgaattta tcctgcagat 900 ttgcctatca gatatgctgg gttctccacg tgcttccgga aagaagctgg ttcacacggg 960 agggacacag ctggcatctt cagagtccac cagtttgaaa agatcgagca gttctgcgcc 1020 acaggtccaa atgacaatgt atcctgggaa atgcatgagg agatgattaa aaatgcagaa 1080 gatttttatc aggcgattgg gctaccatat caactagttt caattgtctc tggtgctctt 1140 aatgatgctg cagctaagaa gtatgatttg gaagcatggt tccctgcatc aaaaaccttc 1200 cgagaattag tgtcctgttc aaattgcaca gattatcagg caaggagact tggaataggc 1260 tatggccaga aaaagaatga tgagcaatcg aagcagttcg ttcatatgtt gaattccacg 1320 ctgactgcaa ctgagaggac actttgctgt attctggaga actaccagcg ggaaggtggt 1380 gttgaagtgc cagaggtgtt gcggccattc atgcttggaa tagatttcct tcctttcaag 1440 cggcctcttg ttgatagcaa acaagctgct gctgactcca aacccaataa gtctaaacca 1500 aagggaaatg cagcttgaac tgaaaattgt ttccaggcag ataatgatgc acccttcctt 1560 ttattaattt caagaatggt ctgtagcatg atgatgattt ggtctcccat tttggatggt 1620 tttggttacg aagtattgca atccaggaca cataatttac cgcaaagtat attaatgttt 1680 ttcatgacta aaaaaaaaaa aaaaaaaact cgagactag 1719 20 458 PRT Triticum aestivum 20 Met Leu Asp Ile Asn Leu Phe Arg Lys Glu Lys Gly Gly Asp Pro Glu 1 5 10 15 Leu Val Arg Gln Ser Gln Arg Ser Arg Phe Ala Pro Val Glu Leu Val 20 25 30 Asp Glu Val Ile Val Leu Asp Glu Ala Trp Arg Gln Arg Gln Phe Glu 35 40 45 Leu Asp Lys Ile Arg Gln Glu Leu Asn Lys Thr Ser Lys Glu Ile Gly 50 55 60 Lys Leu Lys Ala Lys Lys Gln Asp Ala Thr Glu Leu Ile Gln Ser Thr 65 70 75 80 Glu Glu Ile Lys Lys Arg Leu Ala Ala Lys Glu Thr Asp Val Gln Glu 85 90 95 Ala Lys Thr Thr Leu Asp Ala Lys Leu Val Thr Ile Gly Asn Leu Val 100 105 110 His Glu Ser Val Pro Ile Ser Asn Asp Glu Ala Asn Asn Ala Ile Val 115 120 125 Arg Thr Trp Gly Glu Lys Arg Leu Glu Glu Lys Leu Lys Asn His Val 130 135 140 Asp Leu Cys Ile Met Leu Asp Ile Val Ser Leu Asp Lys Gly Ala Asp 145 150 155 160 Val Ala Gly Gly Arg Gly Phe Phe Leu Lys Gly Asp Gly Val Leu Leu 165 170 175 Asn Gln Ala Leu Ile Asn Phe Gly Leu Ser Phe Leu Gly Lys Arg Glu 180 185 190 Phe Thr Pro Met Gln Thr Pro Phe Phe Met Arg Lys Glu Ile Met Ala 195 200 205 Lys Cys Ala Gln Leu Ala Gln Phe Asp Glu Glu Leu Tyr Lys Val Thr 210 215 220 Gly Asp Gly Glu Asp Lys Tyr Leu Ile Ala Thr Ser Glu Gln Pro Leu 225 230 235 240 Cys Ala Tyr His Leu Gly Asp Arg Ile Tyr Pro Ala Asp Leu Pro Ile 245 250 255 Arg Tyr Ala Gly Phe Ser Thr Cys Phe Arg Lys Glu Ala Gly Ser His 260 265 270 Gly Arg Asp Thr Ala Gly Ile Phe Arg Val His Gln Phe Glu Lys Ile 275 280 285 Glu Gln Phe Cys Ala Thr Gly Pro Asn Asp Asn Val Ser Trp Glu Met 290 295 300 His Glu Glu Met Ile Lys Asn Ala Glu Asp Phe Tyr Gln Ala Ile Gly 305 310 315 320 Leu Pro Tyr Gln Leu Val Ser Ile Val Ser Gly Ala Leu Asn Asp Ala 325 330 335 Ala Ala Lys Lys Tyr Asp Leu Glu Ala Trp Phe Pro Ala Ser Lys Thr 340 345 350 Phe Arg Glu Leu Val Ser Cys Ser Asn Cys Thr Asp Tyr Gln Ala Arg 355 360 365 Arg Leu Gly Ile Gly Tyr Gly Gln Lys Lys Asn Asp Glu Gln Ser Lys 370 375 380 Gln Phe Val His Met Leu Asn Ser Thr Leu Thr Ala Thr Glu Arg Thr 385 390 395 400 Leu Cys Cys Ile Leu Glu Asn Tyr Gln Arg Glu Gly Gly Val Glu Val 405 410 415 Pro Glu Val Leu Arg Pro Phe Met Leu Gly Ile Asp Phe Leu Pro Phe 420 425 430 Lys Arg Pro Leu Val Asp Ser Lys Gln Ala Ala Ala Asp Ser Lys Pro 435 440 445 Asn Lys Ser Lys Pro Lys Gly Asn Ala Ala 450 455 21 2445 DNA Zea mays 21 ggcgaccggc cagcgccata tcccgcgccg ccgccgccgc cgccgccgcc gccaacgctt 60 aatgctagtg ttcctccggc gaggcctctt gctcgtccgg cagcccacca cccgcgtcct 120 tgccaaaccg tctctccgcc ctgcttgtct cttcgtccac cacttcgccg tcgacacgat 180 gggtgagggt tctgctgctg gtaaggacgc gaaggggaag gggaagggga aggggaagac 240 caaggccgcc gccgcggatt cggccctggt cgttcgcgac gactcctacc tagaggcggt 300 cactcagaag aggattcgct tcttcgagga gatccaggca aggcaagccg tcgagcggct 360 gaatatcggc ggcgaagtta tcaaggtaac tttgcctgat ggcgctatca aggagggtaa 420 gaaatggata acaaccccaa tggatattgc taaggagata tcaagtggat ttgcagctag 480 ttgtttgata gctcaagtgg acgaaacact ctgggacatg gggaggccac tcgaaggtga 540 ttgtaaattg caaatgttca agtttgatac caatgaaggt cgtgacacct tctggcactc 600 aagtgctcat attcttggag aatctattga gagagcatat ggatgcaagc tgtgtattgg 660 gccttgcacc acaagagggg agggtttcta ctatgatgct tactacaatg atcagacatt 720 gaatgaggag cactttggta tcattgaaaa ccaagctaaa aaggctgttg cggaaaagca 780 accgtttgaa cgcattgagg tcagcagggc agaagctctt gaaatgtttg ctgagaatga 840 attcaaggtt gaaatcatta atgagttgcc tgaggacaag accattactg tatacaggtg 900 tggtccttta gttgacctat gccgtgggcc acacatccca aatacttcct ttgtcaaagc 960 tttcgcttgt ctgaaggctt catcatcata ttggagagga aaagttgacc gcgaaagcct 1020 gcagagagta tatggaattt ctttccctga ttctcgacgt ctcacggaat ataaacattt 1080 tctagaggaa gctaagaaac gtgatcatag gatattaggg aaagcacagg aactcttctt 1140 tttccatgaa cttagccctg gaagctgctt cttccttcca catggtgcca ggatatataa 1200 caaactgatg gacttcatgc gacaacagta cagagataga ggataccaag aggtgttgag 1260 cccaaatatt tacaatatgc aactatggga aacttctgga cacgccgcaa actataagga 1320 gaacatgttt gtttttgaga tcgagaaaca ggaatttgga cttaagccaa tgaattgtcc 1380 aggacactgt ctaatgtttg ctaatagggt tcggtcgtac agagagttgc ctcttcgcat 1440 ggctgatttt ggagtgcttc atagaaatga gcttagtggt gctcttacag gtttgacacg 1500 tgttagaaga ttccagcagg atgatgctca tatcttctgc agagaagacc aaatcaagga 1560 tgaagttaag gctgttttgg aattcatcaa ttatgtttat gagatatttg gcttcaaata 1620 tgagttggag ttgtctacga gaccagagaa gtatctaggt gaagttgaaa cttggaacaa 1680 agctgaacaa caattgacag aagctttaaa tgagtttggg aagccatgga agattaatga 1740 aggggatggt gctttctacg gcccaaaaat tgatattggt gtgtttgatg cccttaagag 1800 gaaatttcag tgtgcaaccc tacagctgga ttttcagctg cccattcggt tcaagctggc 1860 ttattctgct gaggatgaag ccaaaattga aaggcctgtg atgatacaca gggcaatcct 1920 aggttcggtt gaaaggatgc ttgccattct tttggagcat tacaatggta aatggccctt 1980 atggctaagc cctcgccagg ccattgtttg ctcggtatct tctggttcag tggaatatgc 2040 gaaacaggtt cttgccactc tacatgaagc tggttttcat gttgatattg acgcgagtga 2100 caggacaata caaaagaagg tacgggaagc tcaactggcc caattcaact acattcttgt 2160 cgtaggtgca caagaggccg agactggaaa tatatgcgtt agggtaagag acaatgctga 2220 cctggtcaca acgagtgtag atggcttcat cacacgtttg agggacgaaa tcgcagcctt 2280 caaatgattt tgatgctgca taatttccta ctactcgttt gtgattttga cgagttttta 2340 gtgaccagca tcgagttcct cgtgttactg ttcttgtttg tatgaagcta aaaggttgtc 2400 tttttgttat taattacaga tgcgaagtta aatactgccg ctagt 2445 22 741 PRT Zea mays 22 Met Leu Val Phe Leu Arg Arg Gly Leu Leu Leu Val Arg Gln Pro Thr 1 5 10 15 Thr Arg Val Leu Ala Lys Pro Ser Leu Arg Pro Ala Cys Leu Phe Val 20 25 30 His His Phe Ala Val Asp Thr Met Gly Glu Gly Ser Ala Ala Gly Lys 35 40 45 Asp Ala Lys Gly Lys Gly Lys Gly Lys Gly Lys Thr Lys Ala Ala Ala 50 55 60 Ala Asp Ser Ala Leu Val Val Arg Asp Asp Ser Tyr Leu Glu Ala Val 65 70 75 80 Thr Gln Lys Arg Ile Arg Phe Phe Glu Glu Ile Gln Ala Arg Gln Ala 85 90 95 Val Glu Arg Leu Asn Ile Gly Gly Glu Val Ile Lys Val Thr Leu Pro 100 105 110 Asp Gly Ala Ile Lys Glu Gly Lys Lys Trp Ile Thr Thr Pro Met Asp 115 120 125 Ile Ala Lys Glu Ile Ser Ser Gly Phe Ala Ala Ser Cys Leu Ile Ala 130 135 140 Gln Val Asp Glu Thr Leu Trp Asp Met Gly Arg Pro Leu Glu Gly Asp 145 150 155 160 Cys Lys Leu Gln Met Phe Lys Phe Asp Thr Asn Glu Gly Arg Asp Thr 165 170 175 Phe Trp His Ser Ser Ala His Ile Leu Gly Glu Ser Ile Glu Arg Ala 180 185 190 Tyr Gly Cys Lys Leu Cys Ile Gly Pro Cys Thr Thr Arg Gly Glu Gly 195 200 205 Phe Tyr Tyr Asp Ala Tyr Tyr Asn Asp Gln Thr Leu Asn Glu Glu His 210 215 220 Phe Gly Ile Ile Glu Asn Gln Ala Lys Lys Ala Val Ala Glu Lys Gln 225 230 235 240 Pro Phe Glu Arg Ile Glu Val Ser Arg Ala Glu Ala Leu Glu Met Phe 245 250 255 Ala Glu Asn Glu Phe Lys Val Glu Ile Ile Asn Glu Leu Pro Glu Asp 260 265 270 Lys Thr Ile Thr Val Tyr Arg Cys Gly Pro Leu Val Asp Leu Cys Arg 275 280 285 Gly Pro His Ile Pro Asn Thr Ser Phe Val Lys Ala Phe Ala Cys Leu 290 295 300 Lys Ala Ser Ser Ser Tyr Trp Arg Gly Lys Val Asp Arg Glu Ser Leu 305 310 315 320 Gln Arg Val Tyr Gly Ile Ser Phe Pro Asp Ser Arg Arg Leu Thr Glu 325 330 335 Tyr Lys His Phe Leu Glu Glu Ala Lys Lys Arg Asp His Arg Ile Leu 340 345 350 Gly Lys Ala Gln Glu Leu Phe Phe Phe His Glu Leu Ser Pro Gly Ser 355 360 365 Cys Phe Phe Leu Pro His Gly Ala Arg Ile Tyr Asn Lys Leu Met Asp 370 375 380 Phe Met Arg Gln Gln Tyr Arg Asp Arg Gly Tyr Gln Glu Val Leu Ser 385 390 395 400 Pro Asn Ile Tyr Asn Met Gln Leu Trp Glu Thr Ser Gly His Ala Ala 405 410 415 Asn Tyr Lys Glu Asn Met Phe Val Phe Glu Ile Glu Lys Gln Glu Phe 420 425 430 Gly Leu Lys Pro Met Asn Cys Pro Gly His Cys Leu Met Phe Ala Asn 435 440 445 Arg Val Arg Ser Tyr Arg Glu Leu Pro Leu Arg Met Ala Asp Phe Gly 450 455 460 Val Leu His Arg Asn Glu Leu Ser Gly Ala Leu Thr Gly Leu Thr Arg 465 470 475 480 Val Arg Arg Phe Gln Gln Asp Asp Ala His Ile Phe Cys Arg Glu Asp 485 490 495 Gln Ile Lys Asp Glu Val Lys Ala Val Leu Glu Phe Ile Asn Tyr Val 500 505 510 Tyr Glu Ile Phe Gly Phe Lys Tyr Glu Leu Glu Leu Ser Thr Arg Pro 515 520 525 Glu Lys Tyr Leu Gly Glu Val Glu Thr Trp Asn Lys Ala Glu Gln Gln 530 535 540 Leu Thr Glu Ala Leu Asn Glu Phe Gly Lys Pro Trp Lys Ile Asn Glu 545 550 555 560 Gly Asp Gly Ala Phe Tyr Gly Pro Lys Ile Asp Ile Gly Val Phe Asp 565 570 575 Ala Leu Lys Arg Lys Phe Gln Cys Ala Thr Leu Gln Leu Asp Phe Gln 580 585 590 Leu Pro Ile Arg Phe Lys Leu Ala Tyr Ser Ala Glu Asp Glu Ala Lys 595 600 605 Ile Glu Arg Pro Val Met Ile His Arg Ala Ile Leu Gly Ser Val Glu 610 615 620 Arg Met Leu Ala Ile Leu Leu Glu His Tyr Asn Gly Lys Trp Pro Leu 625 630 635 640 Trp Leu Ser Pro Arg Gln Ala Ile Val Cys Ser Val Ser Ser Gly Ser 645 650 655 Val Glu Tyr Ala Lys Gln Val Leu Ala Thr Leu His Glu Ala Gly Phe 660 665 670 His Val Asp Ile Asp Ala Ser Asp Arg Thr Ile Gln Lys Lys Val Arg 675 680 685 Glu Ala Gln Leu Ala Gln Phe Asn Tyr Ile Leu Val Val Gly Ala Gln 690 695 700 Glu Ala Glu Thr Gly Asn Ile Cys Val Arg Val Arg Asp Asn Ala Asp 705 710 715 720 Leu Val Thr Thr Ser Val Asp Gly Phe Ile Thr Arg Leu Arg Asp Glu 725 730 735 Ile Ala Ala Phe Lys 740 23 1758 DNA Oryza sativa 23 gcacgagatt atgatgccta ctacaatgat ctgacattga atgagacaca ttttggtatc 60 attgatgccc aagcacagaa agctgttgcg gaaaaacaac catttgaacg aattgaggtc 120 tccagggcag aggcccttga aatgttcgca gaaaataaat ttaaggttga aatcattaat 180 gagttgcctg aagacaagac cattacagta tacagatgtg gtcctctagt tgacctttgc 240 cgtgggccac acatccccaa tacttccttt gttaaagctt ttgcttgtct taaggcatca 300 tcgtcgtatt ggagagggaa agcagatcga gagagcctgc agagagtata tggaatttct 360 tttcctgatt ctaaacgtct caaggaatat aaacatctgc tagaagaggc taagaagcgt 420 gatcataggc tattaggaca gacccaggat ctcttctttt tccatcaact tagtccagga 480 agctgcttct tccttccaca tggtgctata atatacaaca aattgatgga ttttttgcga 540 cagcaataca gagatagagg atatcaagag gttttgagcc caaatattta caatatgcaa 600 ctctgggaaa cctctggaca tgctgcaaac tacaaggaga atatgtttgt ttttgagatt 660 gagaaacagg aatttggtct caagccaatg aattgtcctg gccattgcct aatgtttgag 720 cacagggttc gttcatacag agaattgcct ctccggatgg ctgattttgg agtccttcac 780 aggaatgagc ttagtggtgc acttacaggt ttgacacgtg ttagaagatt ccagcaggat 840 gatgcccata ttttttgcag agaaagccaa atcaaggacg aagttaaggc tgttttggac 900 ttcatcaatt atgtttacga gatatttgga tttaaatatg aattggagct atcaacgaga 960 ccagaaaagt acttaggtga tattgaaacc tggaacaaag cagagcaaca gctgacagaa 1020 gccttaaatg agtttggaaa gccatggcag atcaatgaag gtgatggtgc cttctatggt 1080 ccaaaaattg atattggtgt gtttgatgcc ctcaagagga aatttcagtg tgcaactcta 1140 cagctcgatt ttcagctgcc cctacgcttc aagctgactt actctgcaga ggatgaagcc 1200 aaacttgaga ggcctgtgat gattcacagg gcaatcctag gttctgttga aaggatgttt 1260 gctattcttt tggagcatta caatggtaaa tggcccttgt ggttgagtcc tcgccaagcc 1320 attgtttgct ccatatcttc caattcagtg gaatacgcta aacaggtccg tgctaggata 1380 catgaagctg gttttcatgt agccatcgat gagacagaca ggacaataca gaagaaggta 1440 cgggaggctc aattagccca attcaactac attcttgtcg ttggtgcaca agaagcagag 1500 actggacagg tcagcgtcag ggtaagggac aaagctgaac tagccacagt gagcattgat 1560 gacatcatca cacgttttaa ggaggaagta gcagcttaca aatgattttg atttcacacc 1620 cttttgctaa gaatttactc caaatttgtg attttgatgg tgtagcgggc agtgtaatct 1680 tgctatttta tttcttgaca aaagtacatc tgattgtctt ttcttaataa cgaaagtgtg 1740 ctattcttca tcagcgac 1758 24 530 PRT Oryza sativa 24 Tyr Asp Ala Tyr Tyr Asn Asp Leu Thr Leu Asn Glu Thr His Phe Gly 1 5 10 15 Ile Ile Asp Ala Gln Ala Gln Lys Ala Val Ala Glu Lys Gln Pro Phe 20 25 30 Glu Arg Ile Glu Val Ser Arg Ala Glu Ala Leu Glu Met Phe Ala Glu 35 40 45 Asn Lys Phe Lys Val Glu Ile Ile Asn Glu Leu Pro Glu Asp Lys Thr 50 55 60 Ile Thr Val Tyr Arg Cys Gly Pro Leu Val Asp Leu Cys Arg Gly Pro 65 70 75 80 His Ile Pro Asn Thr Ser Phe Val Lys Ala Phe Ala Cys Leu Lys Ala 85 90 95 Ser Ser Ser Tyr Trp Arg Gly Lys Ala Asp Arg Glu Ser Leu Gln Arg 100 105 110 Val Tyr Gly Ile Ser Phe Pro Asp Ser Lys Arg Leu Lys Glu Tyr Lys 115 120 125 His Leu Leu Glu Glu Ala Lys Lys Arg Asp His Arg Leu Leu Gly Gln 130 135 140 Thr Gln Asp Leu Phe Phe Phe His Gln Leu Ser Pro Gly Ser Cys Phe 145 150 155 160 Phe Leu Pro His Gly Ala Ile Ile Tyr Asn Lys Leu Met Asp Phe Leu 165 170 175 Arg Gln Gln Tyr Arg Asp Arg Gly Tyr Gln Glu Val Leu Ser Pro Asn 180 185 190 Ile Tyr Asn Met Gln Leu Trp Glu Thr Ser Gly His Ala Ala Asn Tyr 195 200 205 Lys Glu Asn Met Phe Val Phe Glu Ile Glu Lys Gln Glu Phe Gly Leu 210 215 220 Lys Pro Met Asn Cys Pro Gly His Cys Leu Met Phe Glu His Arg Val 225 230 235 240 Arg Ser Tyr Arg Glu Leu Pro Leu Arg Met Ala Asp Phe Gly Val Leu 245 250 255 His Arg Asn Glu Leu Ser Gly Ala Leu Thr Gly Leu Thr Arg Val Arg 260 265 270 Arg Phe Gln Gln Asp Asp Ala His Ile Phe Cys Arg Glu Ser Gln Ile 275 280 285 Lys Asp Glu Val Lys Ala Val Leu Asp Phe Ile Asn Tyr Val Tyr Glu 290 295 300 Ile Phe Gly Phe Lys Tyr Glu Leu Glu Leu Ser Thr Arg Pro Glu Lys 305 310 315 320 Tyr Leu Gly Asp Ile Glu Thr Trp Asn Lys Ala Glu Gln Gln Leu Thr 325 330 335 Glu Ala Leu Asn Glu Phe Gly Lys Pro Trp Gln Ile Asn Glu Gly Asp 340 345 350 Gly Ala Phe Tyr Gly Pro Lys Ile Asp Ile Gly Val Phe Asp Ala Leu 355 360 365 Lys Arg Lys Phe Gln Cys Ala Thr Leu Gln Leu Asp Phe Gln Leu Pro 370 375 380 Leu Arg Phe Lys Leu Thr Tyr Ser Ala Glu Asp Glu Ala Lys Leu Glu 385 390 395 400 Arg Pro Val Met Ile His Arg Ala Ile Leu Gly Ser Val Glu Arg Met 405 410 415 Phe Ala Ile Leu Leu Glu His Tyr Asn Gly Lys Trp Pro Leu Trp Leu 420 425 430 Ser Pro Arg Gln Ala Ile Val Cys Ser Ile Ser Ser Asn Ser Val Glu 435 440 445 Tyr Ala Lys Gln Val Arg Ala Arg Ile His Glu Ala Gly Phe His Val 450 455 460 Ala Ile Asp Glu Thr Asp Arg Thr Ile Gln Lys Lys Val Arg Glu Ala 465 470 475 480 Gln Leu Ala Gln Phe Asn Tyr Ile Leu Val Val Gly Ala Gln Glu Ala 485 490 495 Glu Thr Gly Gln Val Ser Val Arg Val Arg Asp Lys Ala Glu Leu Ala 500 505 510 Thr Val Ser Ile Asp Asp Ile Ile Thr Arg Phe Lys Glu Glu Val Ala 515 520 525 Ala Tyr 530 25 2380 DNA Glycine max 25 gcacgagaca ctatgctatg ctatgctctc taatccgttt ccgccgttac gctccttcct 60 accgcactct ccactctctc tttccgacga ttaaccgttt ctcctcctcc gtctcctccg 120 cctccgccgc catggttgct cacgcgaagg acgaggcgta cctcagcgcg acgattccga 180 aacgcatccg tctcttcgag accatcctgg cggagcagca cactcagcgc ctctcgctct 240 ccccggatcc tatcaaggtt actctccccg acggcagcgt caaggaggcg aagaagtggc 300 atacgacgcc gcttgatgtt gcgcgtgaaa tctcgaagaa tttggccaac agcgcgctca 360 tcgcgaaggt caatggcgtg ctctgggaca tgactcgccc tctcgaggac gattgccagc 420 tccagatctt caagttcgac gacgacgaag gccgcgacac cttctggcac tccagcgccc 480 acattctcgg ccagtcactt gagacggagt atggatgcaa gctctgcatt gggccttgca 540 ctacaagagg agagggattc tattatgatg cattttacgg ggagttgggt ctcaatgacg 600 atcactttaa gcagattgag gctggagcat tgaaggctgt tgcggaaaag caaccctttg 660 agcgtattga agttacacgt gatcaggcac ttgagatgtt ttcagataat aagtttaagg 720 ttgagattat caatgatttg cctgccgaca aaactatcac agtatacaga tgtggcccct 780 tggttgattt gtgtcgtgga ccccatatac ctaatacatc ctttgtcaaa gcaattgcgt 840 gcttaaaggc ttcatcagca tattggaggg gggacaaaga tcgggaaagt ttacaaagag 900 tttatggcat atcttatcct gatcagaaaa gtctaaagga atacttgcat cggctggagg 960 aggctaaaaa gtatgatcac aggattttgg gtgtgaaaca ggagcttatt cttcatcatg 1020 aatggagccc gggaagctgg ttttttcttc cgcaaggcac tcggatctac aacaaactca 1080 tggacttcat tcggaatcag tacagagaca ggggctatca agaggtcata tctcccaatg 1140 tatttaacat ggaactgtgg gtgcaatctg gtcatgctgc aaattatagg gaggatatgt 1200 ttatcttaga ggttgacaaa caagagtttg ggttgaaacc aatgaattgc ccagggcact 1260 gcctgatgtt taaacacagg gttcgatcat atagagaact tcctcttcgt ttcgctgatt 1320 ttggggtttt gcatcggaat gaggctagtg gcgccctgag tggattaaca cgtgttagga 1380 gattccagca ggacgatgca catattttct gcagggagtc ccagataaag gatgaagtga 1440 ggaacagctt gaatttcatc aattatgtct ataagatatt tggtttcaca tatgagctga 1500 agctttcaac gaggccagaa aaatacctag gagatattgc aacttgggac aaagctgaaa 1560 gtgctcttaa agaagcttta gatgattttg gcaagccttg gcagttgaat gaaggggatg 1620 gtgcattcta tggaccaaag atagacatca gtgtatctga tgcattgggt aggaaattcc 1680 agtgtgcaac tttgcagctt gacttccagc ttcctgatcg ttttaagttg gaattctcag 1740 ctgaggatga agccaaaatt gagagacctg taatgataca cagagccatt ctaggatctg 1800 ttgaacgcat gtttgccata cttttagagc actacaaggg taaatggcct ttctggctca 1860 gtcctcgtca agcaattgta tgccctgtgt ctgaaaagtc acaagcttat gcattacagg 1920 tgcgagatca gatccaccaa gcagggtatt acgttgatgc tgatacaact gataggaaga 1980 ttcaaaagaa ggtgcgagaa gcacaattag cacaatacaa ctacatcttg gttgttggag 2040 aggaggaagc taatacagga caggtgagtg tacgagttag agacttggca gaacataagg 2100 ttatgagtat tgagaagcta cttgaacatt tcagagacaa agctgcagct ttcgaatgat 2160 actttgcatg tgaaaactgt cgaagaaaat tttcagcccc aaatacctta gttttacaca 2220 gttgtgtgcg cattttgatt ttcaacttaa gcaatttatc ctgattttat ttatgatttg 2280 aatgatcact gtatttcgca ctagaaacat aatgtgaatc ttggtcatac ctggagcgca 2340 ctctggttga tctttatatc aaaaaaaaaa aaaaaaaaaa 2380 26 698 PRT Glycine max 26 Tyr Arg Thr Leu His Ser Leu Phe Pro Thr Ile Asn Arg Phe Ser Ser 1 5 10 15 Ser Val Ser Ser Ala Ser Ala Ala Met Val Ala His Ala Lys Asp Glu 20 25 30 Ala Tyr Leu Ser Ala Thr Ile Pro Lys Arg Ile Arg Leu Phe Glu Thr 35 40 45 Ile Leu Ala Glu Gln His Thr Gln Arg Leu Ser Leu Ser Pro Asp Pro 50 55 60 Ile Lys Val Thr Leu Pro Asp Gly Ser Val Lys Glu Ala Lys Lys Trp 65 70 75 80 His Thr Thr Pro Leu Asp Val Ala Arg Glu Ile Ser Lys Asn Leu Ala 85 90 95 Asn Ser Ala Leu Ile Ala Lys Val Asn Gly Val Leu Trp Asp Met Thr 100 105 110 Arg Pro Leu Glu Asp Asp Cys Gln Leu Gln Ile Phe Lys Phe Asp Asp 115 120 125 Asp Glu Gly Arg Asp Thr Phe Trp His Ser Ser Ala His Ile Leu Gly 130 135 140 Gln Ser Leu Glu Thr Glu Tyr Gly Cys Lys Leu Cys Ile Gly Pro Cys 145 150 155 160 Thr Thr Arg Gly Glu Gly Phe Tyr Tyr Asp Ala Phe Tyr Gly Glu Leu 165 170 175 Gly Leu Asn Asp Asp His Phe Lys Gln Ile Glu Ala Gly Ala Leu Lys 180 185 190 Ala Val Ala Glu Lys Gln Pro Phe Glu Arg Ile Glu Val Thr Arg Asp 195 200 205 Gln Ala Leu Glu Met Phe Ser Asp Asn Lys Phe Lys Val Glu Ile Ile 210 215 220 Asn Asp Leu Pro Ala Asp Lys Thr Ile Thr Val Tyr Arg Cys Gly Pro 225 230 235 240 Leu Val Asp Leu Cys Arg Gly Pro His Ile Pro Asn Thr Ser Phe Val 245 250 255 Lys Ala Ile Ala Cys Leu Lys Ala Ser Ser Ala Tyr Trp Arg Gly Asp 260 265 270 Lys Asp Arg Glu Ser Leu Gln Arg Val Tyr Gly Ile Ser Tyr Pro Asp 275 280 285 Gln Lys Ser Leu Lys Glu Tyr Leu His Arg Leu Glu Glu Ala Lys Lys 290 295 300 Tyr Asp His Arg Ile Leu Gly Val Lys Gln Glu Leu Ile Leu His His 305 310 315 320 Glu Trp Ser Pro Gly Ser Trp Phe Phe Leu Pro Gln Gly Thr Arg Ile 325 330 335 Tyr Asn Lys Leu Met Asp Phe Ile Arg Asn Gln Tyr Arg Asp Arg Gly 340 345 350 Tyr Gln Glu Val Ile Ser Pro Asn Val Phe Asn Met Glu Leu Trp Val 355 360 365 Gln Ser Gly His Ala Ala Asn Tyr Arg Glu Asp Met Phe Ile Leu Glu 370 375 380 Val Asp Lys Gln Glu Phe Gly Leu Lys Pro Met Asn Cys Pro Gly His 385 390 395 400 Cys Leu Met Phe Lys His Arg Val Arg Ser Tyr Arg Glu Leu Pro Leu 405 410 415 Arg Phe Ala Asp Phe Gly Val Leu His Arg Asn Glu Ala Ser Gly Ala 420 425 430 Leu Ser Gly Leu Thr Arg Val Arg Arg Phe Gln Gln Asp Asp Ala His 435 440 445 Ile Phe Cys Arg Glu Ser Gln Ile Lys Asp Glu Val Arg Asn Ser Leu 450 455 460 Asn Phe Ile Asn Tyr Val Tyr Lys Ile Phe Gly Phe Thr Tyr Glu Leu 465 470 475 480 Lys Leu Ser Thr Arg Pro Glu Lys Tyr Leu Gly Asp Ile Ala Thr Trp 485 490 495 Asp Lys Ala Glu Ser Ala Leu Lys Glu Ala Leu Asp Asp Phe Gly Lys 500 505 510 Pro Trp Gln Leu Asn Glu Gly Asp Gly Ala Phe Tyr Gly Pro Lys Ile 515 520 525 Asp Ile Ser Val Ser Asp Ala Leu Gly Arg Lys Phe Gln Cys Ala Thr 530 535 540 Leu Gln Leu Asp Phe Gln Leu Pro Asp Arg Phe Lys Leu Glu Phe Ser 545 550 555 560 Ala Glu Asp Glu Ala Lys Ile Glu Arg Pro Val Met Ile His Arg Ala 565 570 575 Ile Leu Gly Ser Val Glu Arg Met Phe Ala Ile Leu Leu Glu His Tyr 580 585 590 Lys Gly Lys Trp Pro Phe Trp Leu Ser Pro Arg Gln Ala Ile Val Cys 595 600 605 Pro Val Ser Glu Lys Ser Gln Ala Tyr Ala Leu Gln Val Arg Asp Gln 610 615 620 Ile His Gln Ala Gly Tyr Tyr Val Asp Ala Asp Thr Thr Asp Arg Lys 625 630 635 640 Ile Gln Lys Lys Val Arg Glu Ala Gln Leu Ala Gln Tyr Asn Tyr Ile 645 650 655 Leu Val Val Gly Glu Glu Glu Ala Asn Thr Gly Gln Val Ser Val Arg 660 665 670 Val Arg Asp Leu Ala Glu His Lys Val Met Ser Ile Glu Lys Leu Leu 675 680 685 Glu His Phe Arg Asp Lys Ala Ala Ala Phe 690 695 27 1677 DNA Triticum aestivum 27 cggaaaatga atttaaggtt gaaataatta acgaattgcc cgaggacaag accattacag 60 tatacagatg tggtcctttg gtcgacctct gccgtggccc gcacatccca aatacttcct 120 ttgttaaagc tttcgcttgc ctcaaggctt cagcatcata ctggagagga aaagcagacc 180 gtgagagcct gcagagagta tatggaatct ccttccctga ttctaaacgt ctcaaggaat 240 atcaacatat gatagaggaa gctaagaaac gcgatcatag gttactaggg cagtcccaga 300 aactcttctt tttccatcca cttagcccag gtagctgctt cttccttcca aatggcgcta 360 taatatataa caaattgatg gattttttgc gcaaggagta tagagagaga ggctaccaag 420 aggttctgag tccaaatatt tacaacatgc aactttggga aacctctgga catgctgcaa 480 actacaagga caacatgttt gtttttgaga tcgagaaaca agaatttggc cttaagccaa 540 tgaattgtcc tggccattgc ctaatgtttg gacacgaggt tcgatcgtat agagagttgc 600 ctctccgcat ggctgatttt ggagttctgc acagaaatga acttagtggt gcacttacag 660 gtttgacacg tgtcagaaga ttccaacagg acgatgccca tattttttgc atggagagcc 720 aaatcaagga tgaagttcgg gcttgcttgg agttcattga ttatgtttat aaaatatttg 780 ggtttgaata tgagctggag ttatcaacga gaccagagaa gtatttaggt gacattgaga 840 cctggaacaa agcagagcaa caactgacag aagcattgaa tgagtttggg aagccatgga 900 agataaatga agcagatggt gctttctatg gcccgaaaat agatattggt gtgtttgatg 960 ccctcaagag gaaatttcag tgtgcaactc tacagctcga ttttcagctg ccacttcgct 1020 tcaagttgac ttattctgca gaggatgaag ccaagcttga gaggcctgta atgatacaca 1080 gggcaatact aggatcagtt gaaaggatgt ttgccattct tttggagcac tataatggta 1140 aatggccgtt gtggttaagc ccccgacaag ccattgtttg ctgtgtatct gccaattcac 1200 taacatatgc aaaagaggtt catgctcaga tacgtgcagc tggttttcat gttgacattg 1260 acatgactga tagaacaatt caaaagaagg tgcgggaggc tcagttagcc caattcaact 1320 atattctagt cgtcggcgca aaagaggcag agtctggaaa ggtctctctg agggtaagag 1380 acagggcaga cctatccaca gagagcattg ctgacgtcat tgcacgtttt aacgacgaag 1440 ttgcgtcttt ccagtgattt ttaagtcgca tcatcttttt tttgtccaag acatctactg 1500 cacaacccac attgtaattt ggtgaagtga ggtgaatgaa aaatcatgat attcttgttc 1560 atgttgtcac atgtacatta actgccatga tgtatcaatt ctataagggc ctctttgatt 1620 cgaaggattt tcatggggat tggaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaa 1677 28 483 PRT Triticum aestivum 28 Glu Asn Glu Phe Lys Val Glu Ile Ile Asn Glu Leu Pro Glu Asp Lys 1 5 10 15 Thr Ile Thr Val Tyr Arg Cys Gly Pro Leu Val Asp Leu Cys Arg Gly 20 25 30 Pro His Ile Pro Asn Thr Ser Phe Val Lys Ala Phe Ala Cys Leu Lys 35 40 45 Ala Ser Ala Ser Tyr Trp Arg Gly Lys Ala Asp Arg Glu Ser Leu Gln 50 55 60 Arg Val Tyr Gly Ile Ser Phe Pro Asp Ser Lys Arg Leu Lys Glu Tyr 65 70 75 80 Gln His Met Ile Glu Glu Ala Lys Lys Arg Asp His Arg Leu Leu Gly 85 90 95 Gln Ser Gln Lys Leu Phe Phe Phe His Pro Leu Ser Pro Gly Ser Cys 100 105 110 Phe Phe Leu Pro Asn Gly Ala Ile Ile Tyr Asn Lys Leu Met Asp Phe 115 120 125 Leu Arg Lys Glu Tyr Arg Glu Arg Gly Tyr Gln Glu Val Leu Ser Pro 130 135 140 Asn Ile Tyr Asn Met Gln Leu Trp Glu Thr Ser Gly His Ala Ala Asn 145 150 155 160 Tyr Lys Asp Asn Met Phe Val Phe Glu Ile Glu Lys Gln Glu Phe Gly 165 170 175 Leu Lys Pro Met Asn Cys Pro Gly His Cys Leu Met Phe Gly His Glu 180 185 190 Val Arg Ser Tyr Arg Glu Leu Pro Leu Arg Met Ala Asp Phe Gly Val 195 200 205 Leu His Arg Asn Glu Leu Ser Gly Ala Leu Thr Gly Leu Thr Arg Val 210 215 220 Arg Arg Phe Gln Gln Asp Asp Ala His Ile Phe Cys Met Glu Ser Gln 225 230 235 240 Ile Lys Asp Glu Val Arg Ala Cys Leu Glu Phe Ile Asp Tyr Val Tyr 245 250 255 Lys Ile Phe Gly Phe Glu Tyr Glu Leu Glu Leu Ser Thr Arg Pro Glu 260 265 270 Lys Tyr Leu Gly Asp Ile Glu Thr Trp Asn Lys Ala Glu Gln Gln Leu 275 280 285 Thr Glu Ala Leu Asn Glu Phe Gly Lys Pro Trp Lys Ile Asn Glu Ala 290 295 300 Asp Gly Ala Phe Tyr Gly Pro Lys Ile Asp Ile Gly Val Phe Asp Ala 305 310 315 320 Leu Lys Arg Lys Phe Gln Cys Ala Thr Leu Gln Leu Asp Phe Gln Leu 325 330 335 Pro Leu Arg Phe Lys Leu Thr Tyr Ser Ala Glu Asp Glu Ala Lys Leu 340 345 350 Glu Arg Pro Val Met Ile His Arg Ala Ile Leu Gly Ser Val Glu Arg 355 360 365 Met Phe Ala Ile Leu Leu Glu His Tyr Asn Gly Lys Trp Pro Leu Trp 370 375 380 Leu Ser Pro Arg Gln Ala Ile Val Cys Cys Val Ser Ala Asn Ser Leu 385 390 395 400 Thr Tyr Ala Lys Glu Val His Ala Gln Ile Arg Ala Ala Gly Phe His 405 410 415 Val Asp Ile Asp Met Thr Asp Arg Thr Ile Gln Lys Lys Val Arg Glu 420 425 430 Ala Gln Leu Ala Gln Phe Asn Tyr Ile Leu Val Val Gly Ala Lys Glu 435 440 445 Ala Glu Ser Gly Lys Val Ser Leu Arg Val Arg Asp Arg Ala Asp Leu 450 455 460 Ser Thr Glu Ser Ile Ala Asp Val Ile Ala Arg Phe Asn Asp Glu Val 465 470 475 480 Ala Ser Phe 

What is claimed is:
 1. An isolated polynucleotide comprising: (a) a nucleotide sequence encoding a polypeptide having seryl-tRNA synthetase activity, wherein the amino acid sequence of the polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 80% sequence identity based on the Clustal alignment method, or (b) a full-length complement of the nucleotide sequence.
 2. The polynucleotide of claim 1, wherein the amino acid sequence of the polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 85% sequence identity based on the Clustal alignment method.
 3. The polynucleotide of claim 1, wherein the amino acid sequence of the polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 90% sequence identity based on the Clustal alignment method.
 4. The polynucleotide of claim 1, wherein the amino acid sequence of the polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 95% sequence identity based on the Clustal alignment method.
 5. The polynucleotide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:16.
 6. The polynucleotide of claim 1, wherein the nucleotide sequence comprises the nucleotide sequence of SEQ ID NO:15.
 7. A vector comprising the polynucleotide of claim
 1. 8. A recombinant DNA construct comprising the polynucleotide of claim 1 operably linked to a regulatory sequence.
 9. A method for transforming a cell comprising transforming the cell with the polynucleotide of claim
 1. 10. A cell comprising the recombinant DNA construct of claim
 8. 11. A method for producing a plant comprising transforming a plant cell with the polynucleotide of claim 1 and regenerating a plant from the transformed plant cell.
 12. A plant comprising the recombinant DNA construct of claim
 8. 13. A seed comprising the recombinant DNA construct of claim
 8. 